rfhg_230101.1

Basic information about the TSS

---

TSS ID: rfhg_230101.1 Species: human Chr: chr22		Start: 37850003 End: 37850033 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	pELS,CTCF-bound (EH38D3370658,EH38E2163222)
Category:	pELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000451427.1:-383 GeneID: 51386 HGNC/MGI_ID: HGNC:18138 UniProt_ID: C9JHP4 Nearer transcript ids and distances:

Gene_name: eukaryotic translation initiation factor 3 subunit L Gene_symbol: EIF3L Gene_synonyms: EIF3S11 HSPC021 HSPC025 Gene_source: HGNC:18138

TATA-Box annotation

---

Distance to TSS:	599
Nearest PromoterID:	NM_016091
Entrez ID:	51386
Nearest Unigene:	Hs.446852
Nearest Refseq:	NM_016091
Nearest Ensembl:	ENSG00000100129
Gene Name:	eukaryotic translation initiation factor 3 subunit L
Gene Alias:	EIF3EIP|EIF3S11|EIF3S6IP|HSPC021|HSPC025|MSTP005
Gene Type:	protein-coding
CpG%:	0.066667
GC%:	0.548387
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EIF3L p3@EIF3L p4@EIF3L p5@EIF3L p6@EIF3L p7@EIF3L
Sample		p1@EIF3L	p3@EIF3L	p4@EIF3L	p5@EIF3L	p6@EIF3L	p7@EIF3L
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	431.29	1.95	8.96	0.97	1.17	1.36
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	363.36	1.42	5.87	1.01	0.81	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	408.18	0.77	9.07	1.93	1.35	1.93
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	389.83	0.62	8.52	1.04	1.25	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	370.29	0.45	6.07	0.67	0.67	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	383.55	0.39	5.43	1.16	0.97	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	490.02	0.87	14.16	2.18	0.22	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	438.66	1.94	12.60	0.97	1.70	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	412.90	0.43	8.33	1.28	0.64	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	570.35	1.16	3.48	1.74	2.32	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	502.06	0.40	5.66	0.81	0.81	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	442.74	0.81	4.07	1.22	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	291.28	0.48	2.26	0.81	0.81	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	337.39	0.60	4.06	1.65	1.20	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	294.86	1.10	3.73	0.22	1.10	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	321.66	0.75	3.52	1.51	0.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	347.92	0.22	3.06	1.31	1.09	1.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	295.69	2.11	0.84	2.53	2.11	2.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	322.03	2.67	4.27	2.67	2.67	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	278.62	0.30	3.31	1.65	0.90	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	289.62	0.40	2.81	1.60	0.94	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	350.25	1.04	3.80	0.52	0.52	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	328.31	0.52	3.88	0.39	1.55	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	313.28	1.21	6.31	1.94	1.21	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	304.69	0.77	2.58	1.55	0.52	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	286.76	0.63	2.85	1.58	1.58	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	332.42	1.10	3.30	3.30	1.10	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	335.48	0.24	4.01	1.89	0.71	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	259.41	0.97	3.07	1.62	1.29	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	295.52	0.18	4.34	2.17	0.72	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	295.38	1.26	5.44	1.88	1.05	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	263.37	0.20	3.32	1.17	0.78	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	264.00	0.42	3.38	1.90	0.84	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	443.19	1.32	4.29	1.81	0.49	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	289.65	0.93	4.11	0.75	0.93	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	277.85	0.57	2.87	1.72	0.96	1.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	284.09	1.43	5.72	2.45	1.84	2.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	312.71	1.21	5.04	2.01	0.81	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	337.09	0.81	6.48	2.16	2.43	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	262.87	0.00	5.52	2.16	1.68	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	279.25	0.24	1.41	0.47	1.41	1.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	360.42	0.29	5.27	1.32	1.17	1.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	249.28	0.84	4.01	0.63	1.05	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	259.97	1.05	4.02	1.22	1.22	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	310.39	0.40	3.61	1.00	1.81	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	289.88	0.47	3.72	2.09	2.09	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	246.62	1.68	4.80	0.48	1.68	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	290.30	0.30	3.87	1.49	0.89	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	250.62	0.48	2.87	1.44	1.91	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	240.82	0.00	3.44	0.00	0.40	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	297.80	3.48	3.07	3.48	1.84	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	287.31	1.11	3.56	2.22	0.44	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1077.40	27.98	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	294.89	2.48	3.55	1.77	0.71	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	300.23	2.32	5.30	4.97	1.99	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	1198.00	4.19	5.03	5.87	1.68	5.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	490.93	2.76	6.43	2.30	0.92	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	296.88	2.27	2.59	2.27	0.65	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	225.46	1.28	3.53	2.25	1.28	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	471.81	2.20	4.40	3.46	2.51	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	272.86	3.53	1.41	3.53	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	265.81	2.80	2.80	4.49	2.24	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	441.06	0.80	2.39	2.39	3.18	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	300.01	1.36	3.40	3.40	2.38	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	219.97	0.65	2.92	3.90	1.30	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	221.15	1.77	4.26	1.42	0.71	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	824.36	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1026.67	7.90	7.90	23.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	191.59	0.98	3.41	1.46	0.49	1.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	229.09	1.49	4.46	1.98	0.50	3.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	214.85	0.47	3.28	0.94	0.47	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	215.27	1.66	3.64	1.66	0.99	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	215.61	1.55	2.47	2.47	0.31	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	179.47	0.31	4.28	0.92	1.83	0.31
Adipocyte - breast, donor1	11376-118A8	231.08	0.63	4.43	0.32	1.27	1.11
Adipocyte - breast, donor2	11327-117E4	195.24	1.44	3.05	2.09	0.64	1.28
Adipocyte - omental, donor1	11473-119C6	229.52	0.13	4.20	0.38	0.00	0.13
Adipocyte - omental, donor2	11474-119C7	171.92	0.00	2.24	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	213.34	0.33	2.34	1.00	1.00	1.67
Adipocyte - perirenal, donor1	11476-119C9	208.62	0.00	2.55	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	170.42	0.00	1.10	0.00	2.20	3.30
Adipocyte - subcutaneous, donor2	11336-117F4	385.69	0.45	7.23	0.90	0.45	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	510.73	0.17	3.65	0.87	1.74	1.56
Adipocyte differentiation, day04, donor1	13019-139D4	205.15	0.39	3.32	0.00	0.78	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	117.62	0.26	3.60	1.29	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	129.35	0.28	2.79	0.28	0.84	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	105.22	0.00	2.94	0.00	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	202.61	0.08	3.46	0.32	0.48	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	117.16	0.00	2.26	0.65	0.65	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	173.82	0.00	3.73	1.07	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	107.39	0.00	3.34	0.00	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	150.97	0.00	2.91	0.42	0.83	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	122.82	0.25	3.27	0.25	0.75	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	152.82	0.00	2.95	0.00	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	75.20	0.00	1.83	0.61	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	112.93	0.00	2.87	0.00	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	26.89	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	59.90	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	191.06	0.18	3.24	0.00	0.36	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	127.19	0.00	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	131.69	0.00	1.64	0.21	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	528.65	0.46	7.55	0.11	0.57	0.34
Anulus Pulposus Cell, donor2	11463-119B5	224.33	0.49	3.18	0.49	0.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	316.30	1.80	4.94	0.45	0.90	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	317.36	1.30	5.21	1.30	2.17	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	286.79	2.14	6.42	0.00	8.56	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	282.78	1.49	3.89	2.09	1.20	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	333.87	3.79	2.53	3.79	1.26	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	257.43	1.98	2.64	3.96	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	262.51	0.97	4.22	0.97	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	289.32	0.00	5.83	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	305.25	1.19	7.72	2.97	2.38	2.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	318.63	0.38	2.64	1.51	1.51	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	297.53	0.73	3.63	1.45	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	228.19	2.51	3.76	3.76	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	326.34	0.16	4.78	0.82	0.66	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	294.80	2.73	6.82	1.36	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	224.53	0.15	4.67	0.30	0.60	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	323.62	0.54	4.82	2.14	1.07	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	253.93	0.38	5.10	0.38	1.13	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	270.49	1.07	6.15	2.67	1.07	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	262.40	2.93	3.90	0.98	1.95	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	294.73	0.17	4.81	0.50	0.50	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	262.96	1.20	1.20	2.40	3.60	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	318.61	0.00	3.54	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	285.60	0.86	5.32	0.69	0.51	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	343.99	0.00	12.58	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	328.63	0.00	6.80	1.46	2.43	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	352.89	0.38	5.69	1.90	0.76	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	317.38	0.00	4.85	3.63	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	336.89	0.00	5.70	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	283.47	0.43	4.28	0.86	0.21	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	219.89	1.29	4.39	1.03	0.52	1.03
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	278.71	2.35	4.69	0.94	0.00	1.88
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	259.81	0.96	3.54	0.96	0.96	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	272.54	0.71	5.71	0.71	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	250.36	0.00	6.43	1.17	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	287.52	0.30	4.82	0.30	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	293.43	1.19	5.94	2.38	2.38	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	343.28	2.03	4.07	1.53	1.53	1.53
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	323.45	0.25	6.11	2.29	3.06	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	240.80	1.91	1.91	3.18	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	296.90	0.86	4.32	0.43	1.29	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	271.17	0.42	6.77	1.91	0.21	0.85
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	239.52	0.29	2.61	0.87	0.87	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	298.54	0.00	4.72	1.89	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	257.85	0.34	2.71	0.34	0.85	0.85
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	229.32	0.00	6.95	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	414.06	0.00	2.11	0.00	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	270.80	0.43	3.43	0.86	1.72	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	292.41	0.00	7.82	1.20	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	335.33	1.46	5.10	2.92	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	325.97	1.38	3.91	2.30	1.38	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	300.94	2.55	2.55	5.10	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	256.52	0.25	8.14	0.76	0.76	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	293.76	0.41	6.19	0.62	0.41	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	250.31	0.00	2.45	1.22	0.61	0.92
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	335.09	1.43	6.21	0.48	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	275.84	0.22	3.99	0.89	1.11	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	318.89	4.58	3.05	1.53	1.53	3.05
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	290.79	1.11	5.54	1.11	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	269.83	0.53	4.77	2.12	1.32	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	255.50	0.36	4.72	0.73	1.82	0.36
Astrocyte - cerebellum, donor1	11500-119F6	163.71	0.00	5.04	0.25	0.12	0.12
Astrocyte - cerebellum, donor2	11580-120F5	89.86	0.17	1.71	0.17	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	91.45	0.00	1.47	0.00	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	464.66	0.35	10.11	0.35	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	303.81	0.97	8.09	1.29	1.13	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	325.32	0.60	5.97	0.75	0.60	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	529.62	0.92	6.54	2.18	1.03	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	514.41	0.50	9.77	1.00	0.88	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	480.56	0.57	9.90	0.80	1.02	1.02
Basophils, donor1	12241-129G9	282.72	0.00	1.83	0.26	0.26	0.26
Basophils, donor2	12242-129H1	468.67	0.00	1.80	0.00	1.08	0.72
Basophils, donor3	12243-129H2	435.99	0.44	2.79	0.29	0.59	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	145.96	0.00	3.45	0.22	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	47.55	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	538.02	0.00	7.17	0.00	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	136.83	0.00	1.88	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	139.74	0.21	3.54	0.62	1.04	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	256.08	0.46	3.68	1.84	1.84	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	366.73	0.54	4.86	1.80	0.90	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	960.37	0.10	9.17	0.82	0.41	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	925.79	0.47	7.69	1.63	0.93	1.16
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	1159.50	0.64	6.08	1.28	0.96	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	1509.92	0.00	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	404.63	0.00	0.56	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	382.71	0.19	0.37	1.67	1.11	0.93
CD14+ Monocytes, donor3	11381-118B4	322.06	0.66	0.88	1.10	1.32	0.66
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	284.74	0.85	5.94	0.57	0.57	1.70
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	273.69	0.38	5.31	0.38	0.38	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	264.31	0.00	5.59	0.33	0.33	1.64
CD14+ monocytes - mock treated, donor1	11863-125A9	448.10	1.88	3.47	1.30	1.88	2.31
CD14+ monocytes - mock treated, donor2	11873-125C1	393.47	0.60	3.32	0.91	0.91	1.21
CD14+ monocytes - mock treated, donor3	11883-125D2	306.78	0.95	3.55	1.66	0.95	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	318.89	1.67	3.35	1.51	1.51	1.34
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	274.63	0.83	3.04	0.83	1.10	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	371.65	0.25	5.21	0.50	1.24	0.50
CD14+ monocytes - treated with BCG, donor1	11860-125A6	327.57	0.59	1.96	1.76	0.98	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	322.27	1.42	1.42	1.07	1.42	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	497.72	1.31	3.05	1.31	0.87	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	371.09	0.23	0.47	0.00	0.23	3.28
CD14+ monocytes - treated with Candida, donor2	11878-125C6	523.28	0.53	1.06	1.06	0.00	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	511.41	1.11	4.44	2.22	1.11	4.44
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	430.03	1.49	2.83	2.68	1.19	1.49
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	423.04	0.40	4.39	0.20	2.59	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	459.91	0.42	5.00	0.62	2.50	1.67
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	464.43	1.14	2.06	0.92	1.14	4.12
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	426.17	0.68	4.30	0.90	2.94	2.71
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	357.90	1.31	5.24	0.44	0.44	1.75
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	320.37	0.54	2.42	1.08	1.34	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	433.88	1.05	2.44	1.92	1.40	1.92
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	366.53	0.84	5.05	0.42	2.10	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	393.33	1.10	1.47	1.29	0.92	0.92
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	277.94	0.00	3.52	0.70	1.06	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	291.31	0.00	4.39	0.44	2.63	1.32
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	307.25	1.05	1.39	1.74	1.92	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	357.55	0.74	1.12	1.49	2.60	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	556.98	1.08	3.88	1.51	2.59	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	369.36	0.41	1.23	1.23	1.64	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	402.87	0.70	0.70	0.23	0.93	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	417.82	0.93	4.64	1.39	1.62	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	687.89	1.74	9.59	1.74	1.53	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	609.83	0.23	5.31	2.08	2.54	1.15
CD14+CD16+ Monocytes, donor3	11912-125G4	565.58	0.65	9.53	0.87	0.65	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	766.31	1.09	7.01	0.78	1.40	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	682.86	0.70	6.11	1.05	1.92	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	556.53	0.67	6.24	0.67	0.67	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	485.34	0.26	5.36	0.51	1.28	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	542.33	0.66	6.59	1.32	2.42	1.76
CD14-CD16+ Monocytes, donor3	11911-125G3	552.05	0.21	7.79	0.00	0.42	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	674.73	2.03	4.06	4.06	4.06	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	654.25	0.68	3.39	2.03	1.36	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	664.85	1.04	7.25	4.14	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	891.77	0.00	9.06	0.00	2.67	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	858.78	0.00	4.29	2.14	1.07	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	595.95	0.00	2.81	0.70	0.70	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	707.49	0.78	9.41	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	722.42	0.00	3.95	2.64	2.64	0.00
CD19+ B Cells, donor1	11544-120B5	585.19	0.82	1.64	0.82	2.47	0.00
CD19+ B Cells, donor2	11624-122B4	708.02	1.45	2.90	3.63	2.18	0.73
CD19+ B Cells, donor3	11705-123B4	583.58	0.50	3.03	1.51	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	547.09	0.00	6.06	1.21	0.40	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	395.90	0.00	9.59	0.00	0.40	0.40
CD34+ Progenitors, donor1	11545-120B6	656.65	0.00	7.03	0.00	2.01	1.00
CD34+ Progenitors, donor2	11625-122B5	751.70	0.00	4.49	0.56	2.25	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1052.11	0.00	12.78	1.13	0.75	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	1218.96	0.45	12.18	1.35	1.35	0.68
CD4+ T Cells, donor1	11225-116C1	832.66	0.00	1.43	0.71	0.71	0.36
CD4+ T Cells, donor2	11306-117C1	693.20	1.84	3.67	3.06	5.51	0.61
CD4+ T Cells, donor3	11382-118B5	537.70	1.52	2.74	1.52	1.83	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	657.74	1.28	5.36	1.28	1.53	2.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	788.79	1.35	5.39	1.35	0.67	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	654.84	0.00	6.32	0.86	0.29	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1005.55	0.47	6.64	1.42	2.84	1.90
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1333.01	0.70	2.11	2.81	1.40	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	1081.16	0.00	6.59	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	509.13	1.30	7.23	0.43	2.02	1.16
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	477.04	2.03	4.24	1.69	1.36	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	359.65	0.81	5.32	1.29	0.16	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	636.58	0.00	3.14	3.59	2.69	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	767.26	1.05	6.99	1.05	1.75	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	715.85	0.88	8.36	0.44	0.88	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	702.45	0.42	10.96	0.84	2.11	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	447.95	0.42	3.95	1.66	1.04	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	487.16	0.67	6.68	1.67	1.00	0.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	1117.65	1.36	3.54	2.45	1.09	1.63
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1251.98	3.22	10.18	1.61	1.07	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1018.55	0.00	12.55	0.00	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	675.14	0.74	5.56	1.67	1.11	1.67
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	587.47	1.08	7.80	1.08	0.87	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	500.79	1.05	5.25	1.05	0.63	1.68
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	700.77	0.00	4.55	1.52	1.01	2.02
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	815.81	1.30	8.67	2.60	0.87	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	857.25	1.31	9.59	1.31	1.31	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	868.00	1.48	4.95	3.46	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	752.40	0.00	3.69	0.92	0.92	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	714.66	2.79	9.77	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1061.74	0.55	6.09	0.55	2.22	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1096.16	1.23	10.55	0.74	1.23	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	777.70	0.00	4.62	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	847.66	1.07	6.09	0.36	1.43	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	728.51	1.38	11.08	0.00	1.38	1.38
CD8+ T Cells, donor1	11226-116C2	582.76	0.33	2.29	1.64	1.31	0.98
CD8+ T Cells, donor2	11307-117C2	390.45	1.50	3.00	1.88	1.88	1.13
CD8+ T Cells, donor3	11383-118B6	612.29	0.76	1.26	1.77	1.51	1.26
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	267.47	0.23	7.80	0.46	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	256.66	0.96	5.51	0.00	0.48	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	319.55	0.27	9.30	1.09	1.37	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	437.41	1.80	14.11	0.00	2.10	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	283.18	0.00	10.32	0.48	0.72	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	281.28	0.68	6.59	0.23	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	297.03	0.22	10.21	0.43	0.22	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	314.00	0.26	9.48	1.05	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	274.85	0.47	8.91	0.23	0.47	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	281.65	1.21	8.15	0.60	1.21	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	266.97	0.00	10.46	0.87	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	303.73	0.53	8.53	0.00	0.53	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	217.12	0.00	2.63	0.00	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	226.35	0.00	3.64	0.46	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	159.62	0.75	3.73	0.00	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	320.18	0.00	10.44	1.44	0.72	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	305.56	0.00	4.89	0.29	0.86	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	287.08	0.24	7.78	0.71	0.47	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	355.25	0.00	9.19	0.32	0.63	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	293.42	0.62	7.38	1.23	0.31	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	284.68	0.00	5.13	0.96	0.96	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	301.77	0.76	8.80	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	265.63	0.39	4.34	1.18	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	254.91	0.76	7.56	2.27	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	198.33	0.00	2.41	1.61	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	163.67	0.00	4.90	0.00	1.40	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	267.47	1.00	4.01	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	65.80	0.00	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	379.95	0.00	7.41	0.49	0.99	1.48
Cardiac Myocyte, donor3	11686-122I3	455.66	0.00	9.05	0.53	0.11	0.32
Chondrocyte - de diff, donor1	11261-116G1	293.97	0.35	6.24	0.35	0.00	0.69
Chondrocyte - de diff, donor2	11338-117F6	314.51	0.00	4.26	0.36	1.78	1.07
Chondrocyte - de diff, donor3	11410-118E6	366.94	0.34	4.78	0.68	1.71	0.57
Chondrocyte - re diff, donor2	11339-117F7	316.03	0.00	10.74	0.90	2.69	0.00
Chondrocyte - re diff, donor3	11411-118E7	196.14	0.00	1.21	1.62	0.81	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	487.03	0.34	8.49	0.80	1.61	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	331.98	0.64	6.84	1.92	1.07	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	340.36	0.27	6.19	0.97	0.53	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	320.31	0.09	3.58	0.18	0.64	0.46
Corneal Epithelial Cells, donor1	11526-119I5	85.85	0.00	0.88	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	129.69	0.00	3.41	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	102.25	0.26	1.28	0.51	0.26	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	174.34	0.33	5.61	0.17	1.16	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	165.59	0.00	5.99	0.63	1.26	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	182.89	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	146.65	0.43	4.43	0.54	0.54	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	748.19	0.34	4.10	0.00	1.02	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	776.26	0.00	1.31	0.65	1.31	0.65
Dendritic Cells - plasmacytoid, donor3	11385-118B8	759.79	0.00	4.84	0.48	1.94	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	272.00	0.00	7.00	0.17	0.67	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	183.07	0.59	4.11	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	190.89	0.28	3.68	0.85	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	149.41	0.00	4.72	0.00	0.79	0.39
Endothelial Cells - Artery, donor1	11264-116G4	211.76	0.29	8.14	0.58	0.29	0.29
Endothelial Cells - Artery, donor2	11341-117F9	326.10	1.88	9.41	0.71	1.41	0.71
Endothelial Cells - Artery, donor3	11413-118E9	259.98	0.53	6.84	1.40	1.75	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	342.23	0.00	5.76	0.44	0.89	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	269.58	0.00	5.78	1.22	0.91	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	281.06	0.28	8.18	0.56	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	328.33	0.30	4.75	0.00	1.19	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	240.03	0.00	9.37	1.56	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	306.83	0.14	2.27	0.85	0.85	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	364.51	0.40	13.20	1.20	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	186.06	0.52	8.39	2.10	0.52	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	523.20	0.62	13.05	1.24	1.24	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	178.15	0.22	4.13	0.43	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	166.22	0.00	3.54	0.12	0.49	0.00
Endothelial Cells - Vein, donor1	11267-116G7	196.79	0.00	13.65	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	296.16	0.00	7.68	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	207.56	0.47	5.18	0.94	1.10	0.16
Eosinophils, donor1	12244-129H3	640.37	0.00	30.49	0.00	0.00	15.25
Eosinophils, donor2	12245-129H4	209.58	0.00	4.95	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	178.34	0.00	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	90.40	0.00	0.98	0.00	0.73	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	60.32	0.00	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	276.57	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	225.78	0.00	3.28	1.64	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	179.12	0.99	3.50	4.60	2.63	3.94
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	344.73	0.87	6.18	1.19	1.73	2.49
Fibroblast - Aortic Adventitial, donor1	11245-116E3	308.90	0.61	8.85	0.97	1.21	1.33
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	153.80	0.00	9.01	0.00	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	289.51	1.27	5.48	1.69	1.05	1.48
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	189.45	0.00	11.59	0.26	1.32	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	271.74	0.66	7.97	0.33	1.33	1.66
Fibroblast - Cardiac, donor1	11268-116G8	242.69	0.00	6.35	1.81	2.72	0.45
Fibroblast - Cardiac, donor2	11345-117G4	239.51	0.00	7.58	0.00	1.52	1.52
Fibroblast - Cardiac, donor3	11417-118F4	198.41	0.16	4.10	0.63	0.79	0.32
Fibroblast - Cardiac, donor4	11452-119A3	352.21	0.00	6.06	0.00	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	255.33	0.63	4.44	1.27	1.52	0.63
Fibroblast - Cardiac, donor6	11460-119B2	240.43	0.30	6.06	1.06	0.15	0.30
Fibroblast - Choroid Plexus, donor1	11492-119E7	248.55	0.13	5.63	0.00	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	287.33	0.00	4.75	0.86	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	386.71	0.00	1.46	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	148.07	0.00	2.54	0.23	0.46	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	832.25	1.19	4.41	1.19	1.02	0.34
Fibroblast - Dermal, donor1	11269-116G9	316.02	0.23	3.52	0.70	0.70	0.23
Fibroblast - Dermal, donor2	11346-117G5	247.16	0.00	8.02	0.47	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	389.37	0.48	3.99	1.81	0.97	0.97
Fibroblast - Dermal, donor4	11450-119A1	308.73	0.68	5.65	1.81	1.13	1.02
Fibroblast - Dermal, donor5	11454-119A5	281.92	0.52	4.54	1.40	0.70	1.40
Fibroblast - Dermal, donor6	11458-119A9	347.91	0.32	6.01	0.81	0.65	0.97
Fibroblast - Gingival, donor1	11237-116D4	408.75	0.00	6.04	0.42	0.62	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	200.17	0.00	3.41	0.26	1.05	0.26
Fibroblast - Gingival, donor2	11318-117D4	427.64	0.53	7.12	1.45	0.92	0.26
Fibroblast - Gingival, donor3	11394-118C8	387.62	0.39	2.61	0.58	0.58	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	140.25	0.00	6.23	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	140.08	0.35	3.35	0.53	0.53	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	232.91	0.16	4.21	0.47	0.16	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	228.67	0.27	3.79	1.08	0.14	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	75.16	0.00	2.47	0.00	0.00	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	208.69	0.29	3.36	0.58	0.29	0.73
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	238.75	0.00	6.00	0.55	0.27	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	166.84	0.00	4.50	0.33	0.33	0.55
Fibroblast - Gingival, donor9 (control)	11927-125I1	224.51	0.15	2.49	0.59	1.17	0.59
Fibroblast - Lung, donor1	11270-116H1	172.64	0.00	2.72	0.00	1.36	2.72
Fibroblast - Lung, donor2	11347-117G6	407.36	0.00	8.95	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	357.71	0.42	4.85	1.06	1.06	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	137.45	0.00	5.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	116.09	0.00	2.80	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	31.91	0.00	0.84	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	224.91	0.00	4.47	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	43.94	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	172.73	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	411.61	0.19	4.07	0.78	0.97	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	348.26	0.00	5.61	0.91	0.76	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	286.10	0.00	7.34	0.31	0.61	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	141.58	0.00	2.29	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	226.25	0.27	2.16	2.70	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	117.48	0.00	1.86	0.58	0.70	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	304.30	0.44	9.95	0.33	0.88	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	119.27	0.00	2.24	0.20	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	126.96	0.00	2.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	384.29	0.40	5.14	0.40	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	246.67	0.20	9.53	0.00	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	453.64	0.18	3.37	0.18	1.07	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	513.41	0.59	5.32	0.99	0.99	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	207.29	0.00	8.72	0.00	0.60	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	384.85	0.54	7.23	0.54	0.65	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	179.18	0.51	10.38	0.25	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	337.02	0.16	7.55	1.31	0.66	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	205.52	0.00	5.81	0.00	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	320.27	0.40	7.84	0.80	0.90	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	208.54	0.60	14.81	0.00	0.60	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	508.01	0.08	5.38	0.66	0.91	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	689.61	0.51	6.84	0.85	2.22	2.22
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	149.76	0.00	6.24	0.66	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	282.50	0.11	9.16	0.53	1.07	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	297.89	0.34	7.59	0.34	0.51	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	539.62	2.67	5.65	2.20	1.25	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1551.19	0.00	22.16	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	284.99	1.74	5.23	0.87	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	170.06	0.17	3.64	0.52	0.00	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	233.70	0.26	4.68	0.78	0.26	1.56
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	132.10	0.00	4.34	0.26	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	636.17	2.30	8.42	3.83	0.77	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	766.96	3.83	23.61	3.19	4.47	3.83
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	890.59	1.71	15.12	3.42	2.85	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	937.57	2.76	5.79	3.58	4.41	14.34
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	518.99	1.60	7.31	2.05	2.05	8.22
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	634.02	1.98	10.50	2.18	1.19	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	919.89	3.70	3.97	6.61	2.64	15.60
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	450.08	1.30	6.20	2.28	1.63	5.22
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	688.98	2.21	10.17	3.10	4.42	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	794.94	1.27	11.87	1.41	1.84	0.85
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	516.58	0.99	6.65	1.48	1.35	1.72
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	581.04	1.07	11.82	3.22	1.34	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	548.97	1.12	3.96	0.50	1.49	2.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	580.70	0.83	4.84	0.97	0.83	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	546.48	0.61	6.10	1.83	1.42	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	533.03	0.46	4.56	0.68	0.68	1.14
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	542.48	1.00	5.61	1.49	1.00	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	352.56	0.22	2.62	0.66	1.09	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	669.26	1.77	8.86	0.89	2.07	1.77
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	614.21	0.48	6.68	1.43	1.43	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	453.10	0.45	4.92	1.12	0.22	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	598.65	1.41	5.85	2.02	1.21	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	649.90	2.04	7.29	0.51	0.51	1.53
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	564.66	0.27	10.11	0.44	0.53	1.24
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	982.50	0.52	9.68	1.46	0.83	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	979.91	0.34	11.61	0.51	0.85	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	622.10	0.33	4.87	1.00	1.33	0.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	662.57	0.25	9.32	0.75	0.92	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	668.28	0.41	7.55	0.20	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	741.05	1.24	7.22	1.44	1.03	1.86
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	709.52	0.81	3.92	0.81	0.81	1.27
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	478.95	0.33	5.50	1.00	0.50	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	601.33	1.10	4.41	1.98	1.32	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	817.28	1.23	6.52	2.09	0.86	1.84
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	483.52	0.32	3.89	0.97	0.97	1.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	727.06	1.28	3.85	2.89	2.57	2.25
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	441.56	0.57	4.26	0.76	0.76	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	449.06	0.79	4.11	1.90	0.47	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	548.27	1.52	4.26	2.43	0.61	1.82
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	424.32	1.15	4.91	0.73	0.94	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	487.85	1.10	5.27	0.66	1.76	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	454.49	0.84	6.17	0.00	0.84	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	241.10	0.00	5.65	0.46	0.65	0.65
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	344.15	0.53	8.56	0.80	0.53	0.80
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	289.79	0.31	5.36	0.61	0.77	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	277.60	0.26	7.12	0.91	0.65	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	362.70	0.27	5.15	0.54	0.27	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	380.87	0.74	5.71	1.29	1.11	0.92
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	441.92	0.66	3.73	1.54	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	329.26	0.99	1.98	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	313.95	0.26	4.88	0.40	0.53	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	316.96	0.20	4.44	1.41	0.81	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	648.11	0.00	6.86	0.00	0.51	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	867.70	1.00	15.33	1.39	3.98	2.39
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	757.59	0.92	10.17	1.39	2.16	1.54
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	843.29	0.61	15.34	0.82	1.84	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	588.93	0.00	18.15	0.94	2.19	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	575.00	0.28	14.41	2.26	1.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	536.38	0.92	14.76	2.31	5.07	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	574.15	0.00	4.95	4.95	9.90	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	648.68	1.16	16.25	3.48	2.32	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	628.95	0.00	20.86	3.21	6.42	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	570.34	1.74	19.13	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	632.73	1.95	14.32	3.91	1.95	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	723.54	2.88	16.06	1.65	3.29	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	539.83	3.33	3.33	3.33	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	702.47	0.56	12.58	3.64	1.96	2.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	671.66	1.63	9.48	3.92	3.27	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	574.60	1.68	8.39	2.52	3.36	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	770.37	0.64	7.00	1.91	1.91	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	724.16	2.72	11.55	3.74	1.70	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	952.19	2.09	12.53	10.44	2.09	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	1020.55	2.29	5.73	4.01	5.73	4.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	729.01	0.89	6.51	2.96	5.62	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	650.55	0.00	5.08	0.00	8.47	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	712.44	1.24	14.50	5.80	5.38	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	721.91	1.38	14.27	1.84	1.84	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	605.88	5.27	15.81	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	679.64	2.31	8.07	1.92	3.08	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	710.94	0.98	9.13	2.61	1.30	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	555.14	1.34	4.01	4.68	4.01	6.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	1128.83	1.93	7.32	4.62	4.62	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	775.06	1.03	9.59	1.71	2.74	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	737.98	0.00	12.42	12.42	9.94	4.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	1116.87	3.30	7.08	4.25	4.72	2.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	822.56	2.41	6.03	1.81	8.45	5.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	973.61	2.54	3.05	2.03	2.03	3.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	1105.18	1.99	5.58	6.38	3.19	3.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	1235.86	0.99	8.88	4.44	8.39	4.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	1065.94	2.36	10.62	8.26	12.98	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	1082.29	2.33	4.08	6.42	5.25	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	1060.78	2.63	3.95	3.07	4.39	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	760.38	0.85	3.39	5.09	8.48	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	547.97	0.60	12.54	4.78	1.79	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	576.96	1.94	8.25	2.43	6.79	3.88
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	179.18	0.00	6.85	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	213.73	1.25	2.91	1.66	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	238.38	0.00	4.50	3.37	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	464.32	0.63	5.07	1.59	1.59	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	402.29	0.42	1.67	1.25	1.67	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	323.76	0.35	9.40	0.58	0.58	1.04
Hep-2 cells mock treated, biol_rep2	11899-125E9	313.13	0.68	8.44	0.68	0.34	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	297.80	0.46	7.51	0.23	0.46	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	321.15	0.98	7.98	2.30	1.31	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	302.38	0.43	8.17	0.43	0.43	1.07
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	285.68	0.22	8.18	0.43	0.86	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	316.82	0.37	6.10	1.00	1.37	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	296.95	0.86	8.75	0.51	0.69	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	290.26	0.64	10.57	0.64	0.96	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	110.81	0.56	3.92	0.00	0.00	1.12
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	55.83	0.00	0.87	0.00	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	457.38	2.64	10.58	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	116.40	0.00	3.17	0.00	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	87.91	0.00	2.18	0.73	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	268.20	0.17	9.44	0.17	0.17	0.00
Hepatocyte, donor1	11523-119I2	173.12	0.00	2.42	0.00	2.42	0.00
Hepatocyte, donor2	11603-120I1	272.57	1.08	3.23	2.15	0.00	0.00
Hepatocyte, donor3	11684-122I1	162.59	0.00	5.52	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	648.77	1.31	9.14	5.87	1.96	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	415.63	0.70	10.84	1.05	0.87	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	347.00	0.27	8.92	0.14	0.41	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	235.61	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	233.64	0.00	6.68	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	325.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	229.81	0.00	1.38	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	200.21	0.00	2.50	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	462.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	225.54	0.00	7.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	233.11	0.00	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	341.11	0.00	4.87	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	258.43	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	250.51	3.63	7.26	0.00	3.63	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	358.66	2.65	3.97	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	250.55	1.11	6.65	2.22	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	230.48	0.00	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	318.08	0.00	3.78	0.00	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	236.63	1.55	6.19	0.00	1.55	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	248.79	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	310.74	0.65	5.81	0.00	2.58	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	275.30	0.00	4.83	1.61	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	191.17	0.00	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	376.47	0.00	4.89	0.00	0.81	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	280.85	0.00	2.94	0.42	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	129.35	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	334.33	0.00	7.23	0.80	3.21	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	223.43	0.00	0.92	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	211.13	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	306.35	0.94	4.72	0.47	0.47	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	253.95	0.00	0.91	0.00	1.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	309.59	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	327.14	1.08	3.23	2.15	0.00	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	240.12	0.00	5.08	0.00	1.27	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	213.59	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	351.36	0.64	8.93	1.91	1.91	1.28
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	240.59	0.00	14.58	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	173.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	322.04	0.71	5.71	2.14	1.43	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	292.01	0.00	9.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	229.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	315.14	0.62	3.40	0.62	1.23	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	252.87	0.00	5.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	273.45	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	273.98	0.00	3.48	1.39	0.70	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	205.82	0.00	2.21	2.21	0.00	4.43
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	233.42	0.00	6.48	3.24	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	264.20	0.00	6.10	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	184.48	2.25	6.75	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	219.53	0.00	10.45	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	297.63	0.00	2.13	0.00	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	239.68	0.00	2.77	0.00	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	173.83	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	227.35	0.00	3.68	0.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	235.97	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	273.18	0.00	12.42	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	241.08	0.00	3.17	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	387.84	0.16	7.18	0.24	0.90	0.49
Keratinocyte - epidermal, donor2	11349-117G8	236.60	0.59	5.86	0.00	0.59	0.59
Keratinocyte - epidermal, donor3	11421-118F8	280.66	0.28	5.40	0.57	0.57	0.66
Keratinocyte - oral, donor1	11251-116E9	748.31	0.57	9.54	0.79	0.57	0.34
Keratocytes, donor1	11527-119I6	109.34	0.00	4.13	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	85.54	0.00	2.34	0.00	0.00	1.17
Keratocytes, donor3	11688-122I5	246.80	0.20	2.37	0.40	0.79	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	70.33	0.00	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	344.12	0.00	7.55	3.24	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	693.49	0.12	9.23	0.69	0.69	0.23
Lens Epithelial Cells, donor3	11690-122I7	224.42	0.00	6.16	0.00	0.30	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	382.53	0.12	10.32	1.66	0.36	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	286.61	0.00	3.07	0.84	1.12	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	350.87	0.63	8.03	0.47	1.42	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	291.98	0.00	5.91	0.54	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	241.73	0.63	3.78	0.32	1.26	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	330.13	0.43	6.68	1.19	0.86	0.75
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	249.11	0.41	6.16	0.82	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	318.55	0.00	6.57	1.01	1.01	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	319.78	0.14	6.05	0.70	1.41	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	313.66	0.00	5.54	0.00	0.79	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	347.05	0.39	5.04	0.97	1.55	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	278.83	0.37	5.37	0.56	0.93	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	280.48	0.35	5.23	0.70	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	331.31	0.24	6.44	0.24	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	317.27	0.14	6.32	0.82	0.55	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	290.10	0.00	4.31	0.62	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	278.08	0.31	4.99	0.00	0.62	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	351.71	0.00	6.40	0.00	0.91	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	267.90	0.33	5.92	0.99	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	328.02	0.29	8.49	0.88	0.59	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	334.81	0.25	8.46	0.75	0.50	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	282.25	0.97	8.24	0.97	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	356.82	0.27	5.12	0.27	0.81	1.08
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	374.36	0.45	10.29	1.21	0.91	0.15
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	316.75	0.00	7.78	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	334.40	0.21	5.03	0.84	1.05	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	323.45	0.30	6.77	1.20	1.20	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	294.41	0.00	8.94	0.00	0.00	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	328.88	0.19	4.70	1.13	0.38	0.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	327.63	0.32	5.73	0.74	0.95	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	253.92	0.00	4.85	0.48	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	296.39	0.33	5.95	0.00	1.32	0.66
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	335.50	0.37	5.95	0.99	1.24	0.62
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	315.42	0.00	7.03	1.11	1.48	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	312.56	0.00	3.71	1.24	0.49	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	318.71	0.27	6.46	1.51	0.14	0.82
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	273.39	0.32	4.82	1.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	339.94	0.30	6.70	0.00	0.61	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	367.13	0.56	6.86	0.14	0.70	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	269.87	0.36	5.33	1.07	1.42	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	289.90	0.00	7.27	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	305.61	0.16	4.98	0.78	1.09	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	247.09	0.36	6.09	0.72	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	279.96	0.00	3.92	0.65	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	293.57	0.71	4.94	0.24	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	356.03	0.00	12.38	1.24	0.87	0.62
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	257.92	0.00	3.59	0.00	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	312.38	0.00	7.76	0.60	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	151.82	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	168.77	1.53	5.37	1.53	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	172.20	0.00	7.42	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	211.56	1.27	5.50	2.96	1.69	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	189.19	0.70	5.63	0.00	0.70	1.41
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	171.85	0.00	3.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	205.59	1.03	3.61	1.55	2.58	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	179.61	0.00	3.57	0.00	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	199.28	0.23	6.79	0.23	0.68	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	209.11	0.87	4.65	2.33	1.45	0.87
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	180.97	0.45	7.65	0.45	1.80	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	229.51	0.14	7.45	0.27	0.41	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	194.63	0.00	4.11	1.54	1.03	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	171.13	0.00	5.29	0.71	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	189.23	0.00	1.33	1.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	201.21	0.51	4.58	1.53	0.51	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	200.37	1.33	6.40	1.60	2.13	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	242.42	0.38	4.53	1.32	1.13	1.70
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	194.50	0.00	3.07	1.84	1.84	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	201.41	0.82	7.34	0.00	1.63	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	205.12	0.62	6.46	1.46	1.04	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	221.41	0.00	6.17	2.52	3.36	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	173.10	1.03	10.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	198.86	0.87	6.68	2.03	2.32	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	191.02	0.30	5.68	0.90	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	164.32	0.55	6.09	0.00	0.55	1.66
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	226.59	0.71	7.07	1.41	1.41	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	195.45	0.74	7.01	2.95	1.84	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	153.12	0.00	5.76	1.15	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	219.89	1.92	5.76	1.54	1.15	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	202.67	1.70	9.06	5.10	3.96	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	176.40	1.64	4.92	1.64	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	201.09	0.00	2.26	0.90	0.90	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	217.60	1.44	5.03	0.72	1.44	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	199.42	0.00	8.22	0.75	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	174.65	0.74	7.80	1.86	2.60	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	189.10	0.00	4.31	1.72	1.29	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	174.68	0.86	0.86	0.86	0.00	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	233.22	0.33	8.66	3.00	1.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	192.46	0.00	10.86	3.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	165.66	0.00	3.55	1.42	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	216.89	0.00	4.81	3.44	3.44	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	206.65	0.00	5.37	2.15	1.07	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	178.44	0.67	2.69	0.67	2.02	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	215.21	0.37	5.93	2.22	2.22	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	170.95	0.00	4.65	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	138.56	1.06	5.29	2.12	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	195.27	0.80	3.60	1.60	3.20	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	197.71	0.73	7.27	1.45	1.45	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	234.55	0.00	4.60	2.30	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	234.31	0.00	8.39	0.99	2.96	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	204.18	0.00	5.65	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	187.55	0.00	8.55	1.01	1.01	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	220.36	0.90	8.11	1.80	1.80	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	192.76	0.00	6.88	6.88	5.16	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	235.59	0.89	6.68	2.23	1.78	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	210.76	1.17	7.82	0.78	1.96	0.78
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	188.02	1.32	7.26	1.98	1.32	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	185.78	0.00	6.23	1.04	0.52	1.04
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	203.91	0.88	5.69	1.31	1.75	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	177.24	1.12	2.80	1.68	2.24	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	193.44	0.44	7.95	0.44	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	198.26	0.77	5.40	1.93	1.93	0.77
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	182.29	0.51	7.09	2.53	1.01	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	170.62	0.00	5.29	0.48	1.44	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	225.81	0.80	5.57	0.40	3.58	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	188.36	1.22	4.86	3.65	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	168.78	0.69	2.77	0.00	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	225.33	1.14	7.22	1.52	1.14	0.76
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	218.96	1.03	6.20	2.58	4.65	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	171.72	0.60	6.05	1.21	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	203.13	0.63	3.80	1.27	0.95	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	215.90	0.00	5.33	2.67	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	221.25	0.00	5.17	0.57	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	218.04	0.00	5.66	2.06	1.54	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	224.23	0.71	9.20	2.83	2.83	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	218.48	0.57	5.67	0.57	1.13	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	227.57	0.00	6.66	1.66	1.25	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	224.73	0.78	7.05	5.48	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	207.94	0.84	5.43	0.84	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	209.55	0.46	2.32	1.86	0.93	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	202.72	0.00	6.02	2.68	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	173.22	0.00	5.35	1.07	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	215.79	0.81	4.45	2.02	2.83	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	192.73	0.00	5.51	0.92	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	174.27	0.89	8.89	0.89	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	234.79	0.57	6.27	0.57	0.57	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	175.62	0.00	9.97	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	157.59	0.55	4.92	0.00	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	166.15	0.45	9.35	0.45	2.67	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	162.21	0.00	7.02	0.26	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	158.48	0.00	7.96	0.66	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	209.94	2.08	8.31	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	129.00	0.46	6.15	0.23	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	118.91	0.18	5.69	0.00	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	135.14	0.26	4.85	0.52	0.79	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	209.22	0.00	7.43	0.00	0.53	0.53
Mallassez-derived cells, donor2	11929-125I3	208.36	0.16	6.50	0.32	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	285.62	0.28	9.87	0.28	0.42	0.28
Mammary Epithelial Cell, donor1	11273-116H4	421.49	0.10	8.67	0.10	0.90	0.30
Mammary Epithelial Cell, donor2	11350-117G9	368.89	0.00	11.29	0.29	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	178.34	0.00	3.99	0.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	468.45	0.00	14.91	0.00	0.68	0.68
Mast cell, donor1	11563-120D6	374.71	0.32	6.16	0.54	0.11	0.65
Mast cell, donor2	11565-120D8	345.32	0.00	4.75	0.30	2.67	1.49
Mast cell, donor3	11566-120D9	337.46	0.23	5.85	0.45	0.90	0.68
Mast cell, donor4	11567-120E1	354.93	0.00	4.08	0.53	0.71	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	333.23	0.11	9.32	0.33	0.67	0.44
Mast cell, expanded and stimulated, donor8	11942-126A7	440.10	0.00	15.18	0.58	1.75	1.17
Mast cell, expanded, donor5	11939-126A4	340.27	0.57	9.06	0.92	1.49	0.69
Mast cell, expanded, donor8	11941-126A6	389.46	0.17	6.36	0.33	0.50	2.85
Melanocyte - dark, donor1	11502-119F8	603.65	0.00	9.45	0.60	0.90	0.60
Melanocyte - dark, donor2	11582-120F7	404.92	0.35	7.27	1.73	2.77	0.00
Melanocyte - dark, donor3	11663-122F7	273.61	0.14	9.42	0.14	0.14	0.07
Melanocyte - light, donor1	11274-116H5	179.36	0.00	4.94	0.24	0.00	0.24
Melanocyte - light, donor2	11351-117H1	184.95	0.68	4.78	1.36	0.00	1.36
Melanocyte - light, donor3	11423-118G1	170.84	0.00	5.20	0.87	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	251.25	0.42	7.39	0.52	0.52	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	277.28	0.00	6.99	0.81	0.00	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	309.64	0.00	6.96	0.27	0.80	0.54
Meningeal Cells, donor1	11493-119E8	197.25	0.00	5.95	0.00	0.12	0.12
Meningeal Cells, donor2	11573-120E7	199.83	0.00	3.96	0.88	0.00	0.00
Meningeal Cells, donor3	11654-122E7	457.63	0.00	14.43	0.33	0.57	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	401.78	0.29	7.98	0.57	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	336.31	0.10	5.03	0.20	0.50	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	69.65	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	45.79	0.00	1.31	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	266.23	0.00	7.18	0.00	1.44	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	315.11	0.00	4.02	0.21	1.06	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	189.50	0.00	5.53	0.00	0.50	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	125.04	0.00	3.30	0.22	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	84.02	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	80.61	0.20	3.07	0.20	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	602.92	0.28	8.17	0.83	0.69	0.69
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	105.20	0.00	2.60	0.00	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	653.13	0.13	6.18	0.66	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	203.86	0.00	1.48	0.30	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	107.44	4.67	2.34	2.34	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	103.10	0.00	3.20	0.00	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	348.42	0.35	7.80	0.35	0.00	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	544.45	0.31	5.32	0.00	0.63	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	285.92	0.00	9.43	0.00	1.45	0.73
Mesothelial Cells, donor1	11247-116E5	194.90	0.00	6.10	0.80	0.53	0.53
Mesothelial Cells, donor2	12156-128G5	143.63	0.00	5.51	0.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	149.95	0.36	2.89	0.29	0.22	0.07
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	39.16	0.00	1.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	172.15	0.00	3.45	0.49	0.99	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	135.16	0.00	4.42	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	165.51	0.00	2.17	0.93	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	147.28	0.00	3.94	0.62	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	6.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	172.18	0.00	4.25	1.00	0.25	1.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	94.96	0.00	2.79	0.47	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	162.17	0.20	3.05	0.41	0.20	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	97.01	0.00	0.79	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	227.43	0.88	7.08	2.65	2.65	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	180.09	0.00	4.94	1.14	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	9.21	0.00	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	215.62	0.64	3.61	1.06	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	36.83	0.92	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	101.34	0.00	1.49	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	21.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	184.92	0.00	2.51	1.00	0.75	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	92.22	0.00	1.66	0.00	0.24	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	14.93	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	141.83	0.46	2.07	0.23	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	92.34	0.21	2.10	0.42	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	113.94	0.20	0.82	0.20	0.00	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	166.05	0.00	3.00	0.21	0.86	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	59.35	0.22	0.44	0.00	0.67	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	100.09	0.00	2.41	1.10	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	35.99	0.00	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	3.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	75.29	0.27	1.36	0.54	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	72.05	0.00	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	10.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	114.37	0.00	0.96	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	93.65	0.00	1.60	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	13.71	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	113.13	0.50	2.50	0.50	2.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	8.15	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	80.14	1.31	1.31	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	14.35	0.00	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	89.99	0.25	1.74	0.50	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	13.92	0.00	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	6.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	70.43	0.00	3.08	0.34	0.34	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	22.32	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	11.36	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	98.47	0.00	3.09	0.28	0.56	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	23.69	0.00	0.83	0.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	13.40	0.00	1.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	41.33	0.60	0.90	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	62.61	0.00	2.92	0.00	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	32.32	0.00	3.69	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	39.27	0.00	0.57	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	29.57	0.00	1.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	53.64	0.52	2.59	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	28.74	0.00	2.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	7.62	0.00	0.64	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	26.42	0.00	1.07	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	57.77	0.60	2.10	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	20.62	0.00	0.85	0.14	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	57.33	0.00	3.50	0.00	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	46.88	0.00	2.65	0.00	0.66	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	16.31	0.00	0.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	50.29	0.00	2.56	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	67.60	0.00	3.44	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	13.69	0.65	1.96	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	43.22	0.00	2.94	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	56.22	0.00	4.32	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	50.69	0.00	1.65	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	33.35	0.00	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	278.75	0.00	0.00	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	254.86	0.00	7.13	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	241.17	0.33	3.61	0.66	1.64	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	210.39	0.00	5.26	1.05	3.16	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	194.13	0.00	2.37	0.99	1.19	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	197.44	0.00	2.79	1.86	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	326.33	0.75	6.38	2.25	1.13	2.63
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	190.17	0.27	4.26	0.53	0.53	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	159.36	0.11	2.94	0.34	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	264.48	0.00	2.21	1.47	3.68	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	201.90	0.37	2.93	1.10	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	205.34	1.56	4.67	3.11	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	262.94	0.53	3.74	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	297.52	0.00	3.86	0.00	0.00	11.59
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	256.52	0.00	5.05	5.05	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	191.85	0.42	4.64	0.00	0.84	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	239.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	231.43	0.64	1.91	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	229.99	0.00	3.24	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	179.74	0.00	1.51	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	199.86	0.00	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	172.91	0.00	0.00	0.00	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	264.12	0.00	9.91	0.22	0.22	0.65
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	297.37	2.09	7.32	0.00	1.05	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	92.78	0.00	3.34	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	35.89	0.00	0.83	0.00	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	178.16	0.19	2.47	0.19	0.38	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	102.13	0.00	4.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	65.27	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	264.62	0.00	5.51	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	95.01	0.00	2.09	0.00	0.42	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	115.75	0.23	2.32	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	82.42	0.54	1.08	0.81	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	136.44	0.00	1.89	0.00	0.21	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	367.45	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	156.35	0.00	0.99	0.00	0.99	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	205.71	0.27	2.71	0.54	0.27	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	121.50	0.00	1.36	1.36	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	107.94	0.00	0.98	0.00	0.49	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	170.59	0.00	2.55	1.46	1.09	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	176.64	0.00	2.65	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	116.46	0.00	1.20	1.20	2.40	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	364.60	0.00	2.95	0.33	1.64	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	100.83	0.00	1.14	0.49	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	151.16	0.00	1.41	0.35	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	146.27	0.70	0.70	1.41	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	119.98	0.46	2.30	0.46	0.92	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	161.32	0.32	1.93	1.29	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	460.43	0.69	3.79	0.34	2.41	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	432.36	0.00	5.06	0.00	7.59	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	116.07	0.22	2.01	0.22	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	110.51	0.42	1.69	0.42	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	155.70	0.47	2.37	0.47	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	169.55	0.43	3.00	2.15	1.72	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	550.69	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	144.29	0.00	1.00	0.33	1.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	83.86	0.00	0.90	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	122.61	0.40	1.19	0.79	0.00	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	143.94	0.00	2.79	2.79	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	244.43	0.00	2.65	0.38	1.14	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	84.08	0.33	2.28	0.00	0.65	1.30
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	84.54	0.00	0.87	0.00	0.44	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	118.95	0.45	3.17	0.45	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	124.35	0.00	3.53	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	183.50	0.00	1.33	2.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	220.74	0.00	1.98	0.99	0.50	3.47
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	89.96	0.38	0.77	0.00	1.15	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	287.63	0.00	3.33	0.91	0.30	0.91
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	142.78	0.00	3.09	0.88	1.11	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	170.09	0.00	2.03	3.39	1.36	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	510.95	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	222.53	0.00	1.22	1.22	0.61	1.83
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	82.78	0.00	0.31	0.63	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	122.27	0.00	0.61	1.82	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	181.96	1.58	0.79	1.58	0.79	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	392.24	1.13	3.40	2.27	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	546.25	0.00	0.00	0.00	5.06	0.00
Myoblast, donor1	11241-116D8	149.20	0.37	4.35	0.62	0.62	0.25
Myoblast, donor2	11322-117D8	253.54	0.77	2.88	1.15	1.15	0.58
Myoblast, donor3	11398-118D3	197.25	0.17	5.38	0.17	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	519.52	0.00	3.65	1.61	1.02	0.58
Natural Killer Cells, donor1	11230-116C6	537.54	0.00	2.15	0.31	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	420.97	1.81	2.11	0.90	1.81	1.21
Natural Killer Cells, donor3	11387-118C1	416.88	0.00	2.02	1.47	0.92	0.74
Neural stem cells, donor1	11275-116H6	464.20	0.00	16.33	0.00	0.36	0.00
Neural stem cells, donor2	11352-117H2	573.84	0.00	13.48	0.00	0.00	0.00
Neurons, donor1	11494-119E9	568.95	0.00	14.79	0.00	2.28	1.14
Neurons, donor2	11574-120E8	477.31	0.22	13.87	0.88	1.54	0.66
Neurons, donor3	11655-122E8	501.52	0.82	9.87	4.11	2.47	3.29
Neutrophils, donor1	11233-116C9	105.79	0.00	3.71	0.00	0.00	0.93
Neutrophils, donor2	11314-117C9	75.37	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	125.22	0.00	4.89	1.22	0.61	1.83
Nucleus Pulposus Cell, donor1	11252-116F1	657.44	0.47	5.70	0.47	0.71	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	358.49	0.00	3.58	0.00	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	350.77	0.20	3.41	0.00	1.60	0.60
Olfactory epithelial cells, donor1	11933-125I7	259.34	0.69	3.03	0.83	1.24	0.96
Olfactory epithelial cells, donor2	11934-125I8	314.68	0.87	6.95	2.75	2.32	1.30
Olfactory epithelial cells, donor3	11935-125I9	304.53	0.23	3.29	0.57	1.25	0.34
Olfactory epithelial cells, donor4	11936-126A1	295.80	0.10	1.75	0.68	0.29	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	349.06	0.60	6.02	0.00	0.00	1.20
Osteoblast - differentiated, donor1	11276-116H7	475.37	0.00	4.47	0.64	1.49	0.85
Osteoblast - differentiated, donor2	11353-117H3	198.90	2.29	2.29	1.14	4.57	2.29
Osteoblast - differentiated, donor3	11425-118G3	335.18	0.00	2.48	1.24	2.48	1.24
Osteoblast, donor1	11277-116H8	286.32	0.20	5.08	0.78	0.20	0.39
Osteoblast, donor2	11354-117H4	313.94	0.00	16.86	0.00	0.70	0.70
Osteoblast, donor3	11426-118G4	191.24	0.18	4.80	0.71	0.89	0.36
Pancreatic stromal cells, donor1	11249-116E7	361.12	0.67	5.22	0.34	1.77	0.93
Pericytes, donor1	11491-119E6	97.47	0.00	1.45	0.22	0.00	0.22
Pericytes, donor2	11571-120E5	72.44	0.00	1.13	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	104.78	0.20	3.26	0.00	0.61	0.81
Perineurial Cells, donor1	11499-119F5	455.14	0.11	8.02	0.57	0.34	0.23
Perineurial Cells, donor2	11579-120F4	489.50	0.09	5.89	0.55	0.55	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	580.74	0.32	4.78	0.96	0.32	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	438.55	0.00	3.43	1.47	2.45	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	381.91	0.65	3.62	0.91	0.65	0.65
Placental Epithelial Cells, donor1	11278-116H9	173.63	0.00	7.89	0.24	0.48	0.72
Placental Epithelial Cells, donor2	11355-117H5	300.51	1.11	7.76	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	277.21	0.00	2.36	0.39	0.39	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	177.85	1.27	4.11	1.90	1.27	2.53
Preadipocyte - breast, donor1	11467-119B9	266.75	0.19	5.63	0.00	0.19	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	123.09	0.13	6.27	0.13	0.00	0.26
Preadipocyte - breast, donor2	11328-117E5	242.26	0.90	4.73	1.80	1.13	1.35
Preadipocyte - omental, donor1	11468-119C1	256.91	0.53	4.90	0.64	1.28	0.75
Preadipocyte - omental, donor2	11329-117E6	199.03	0.00	2.18	0.87	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	169.32	0.14	5.16	0.29	0.86	0.57
Preadipocyte - perirenal, donor1	11469-119C2	173.23	0.98	4.92	0.98	2.95	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	193.18	0.00	8.29	0.31	0.31	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	305.81	0.71	11.69	1.59	1.24	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	365.94	0.51	8.00	0.85	0.51	1.70
Preadipocyte - visceral, donor1	11280-116I2	364.21	0.09	9.13	0.65	0.28	0.84
Preadipocyte - visceral, donor2	11357-117H7	292.67	0.00	9.20	1.84	2.30	0.92
Preadipocyte - visceral, donor3	11429-118G7	233.54	0.42	6.58	1.57	0.94	1.25
Prostate Epithelial Cells (polarized), donor1	11253-116F2	568.86	0.15	12.82	0.75	2.41	1.66
Prostate Epithelial Cells, donor2	11331-117E8	163.71	1.08	3.93	2.03	0.27	1.22
Prostate Epithelial Cells, donor3	11404-118D9	231.72	0.43	3.06	0.61	0.86	1.04
Prostate Stromal Cells, donor1	11254-116F3	316.42	0.57	7.40	0.46	0.80	0.34
Prostate Stromal Cells, donor2	11332-117E9	305.17	1.08	7.17	1.61	1.43	1.08
Prostate Stromal Cells, donor3	11405-118E1	286.86	0.31	3.96	2.29	1.04	0.94
Renal Cortical Epithelial Cells, donor1	11516-119H4	135.04	0.00	3.28	0.00	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	464.04	0.42	6.03	0.42	0.55	0.28
Renal Epithelial Cells, donor1	11517-119H5	56.30	0.00	1.52	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	81.80	0.00	0.71	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	455.75	0.11	5.82	0.32	0.74	0.74
Renal Glomerular Endothelial Cells, donor1	11514-119H2	51.74	0.00	1.36	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	109.56	0.13	2.96	0.94	0.40	0.54
Renal Glomerular Endothelial Cells, donor3	11675-122H1	190.93	0.00	6.44	0.22	0.89	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	61.89	0.00	0.67	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	121.27	0.00	2.86	0.22	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	116.62	0.00	1.25	0.00	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	59.09	0.00	0.55	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	150.05	0.00	2.68	0.27	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	84.34	0.00	1.69	0.00	0.42	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	89.48	0.00	2.51	0.19	0.00	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	526.34	0.52	6.74	0.52	0.78	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	212.90	0.28	2.84	0.28	0.85	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	86.45	0.00	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	649.85	0.25	6.77	0.25	0.50	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	390.35	0.13	3.47	0.27	0.94	1.34
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	174.21	0.00	0.89	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	593.30	0.55	12.11	0.55	0.55	2.20
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	261.60	0.00	4.06	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	180.21	0.39	7.15	0.52	0.52	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	187.59	0.30	3.97	0.60	0.40	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	309.07	0.22	7.03	0.33	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	339.01	0.25	9.06	0.74	0.25	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	238.92	0.23	5.48	1.17	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	300.70	0.69	4.62	0.46	0.46	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	184.28	0.00	3.83	0.14	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	223.28	0.61	4.24	0.91	1.06	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	180.98	0.00	7.17	0.18	0.18	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	235.70	0.14	6.89	0.14	0.14	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	223.97	0.21	4.29	0.86	0.64	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	223.04	0.00	3.76	0.66	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	189.46	0.00	6.12	0.38	0.57	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	169.74	0.19	4.38	0.19	0.37	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	313.05	0.00	7.52	0.00	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	150.22	0.00	5.18	0.80	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	177.16	0.10	4.67	0.29	0.10	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	257.41	0.00	7.64	0.76	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	190.63	0.11	6.30	0.32	0.32	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	213.31	0.28	4.20	0.56	1.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	189.53	0.17	4.44	0.34	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	160.45	0.00	3.65	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	194.86	0.25	4.78	0.86	0.37	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	222.70	0.00	6.58	0.40	0.54	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	315.60	0.71	10.61	0.47	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	198.22	0.20	4.17	1.39	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	234.08	0.23	7.95	0.94	0.70	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	227.88	0.21	8.50	0.21	0.62	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	218.33	0.00	4.20	1.33	1.77	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	170.66	0.00	4.18	0.21	1.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	199.19	0.00	6.19	0.13	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	128.91	0.00	4.26	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	171.97	0.19	4.82	0.58	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	254.30	0.17	9.97	0.17	0.69	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	115.50	0.00	5.62	0.27	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	191.91	0.00	5.25	0.33	0.66	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	208.27	0.17	5.28	0.68	1.02	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	228.00	0.00	4.14	0.15	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	172.46	0.00	4.26	0.27	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	254.83	0.28	4.42	0.14	0.69	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	247.39	0.24	3.81	0.48	0.71	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	221.90	0.00	3.63	0.00	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	306.73	0.09	4.90	0.28	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	396.88	0.35	5.24	0.70	0.35	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	192.51	0.00	1.81	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	272.07	0.12	5.39	0.61	0.98	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	275.97	0.15	7.86	0.29	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	300.56	0.00	5.48	0.00	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	264.63	0.00	4.82	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	267.81	0.23	6.56	1.13	2.26	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	288.16	0.30	3.89	0.60	0.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	268.62	0.47	8.74	0.59	1.77	3.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	247.17	1.28	6.19	1.71	2.13	4.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	231.38	0.00	4.81	1.80	0.00	1.80
Schwann Cells, donor1	11498-119F4	84.44	0.00	1.13	0.00	0.19	0.00
Schwann Cells, donor2	11578-120F3	381.07	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	279.55	0.66	6.79	1.31	2.19	0.66
Sebocyte, donor1	11220-116B5	379.60	0.00	10.96	1.10	0.55	0.55
Sebocyte, donor2	11301-117B5	274.35	0.00	6.43	1.84	0.92	0.92
Sebocyte, donor3	11378-118B1	316.80	1.03	5.36	1.65	1.65	1.86
Sertoli Cells, donor1	11255-116F4	324.69	0.00	9.94	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	361.52	8.47	0.00	5.65	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	693.79	0.18	8.36	0.53	0.79	1.94
Skeletal Muscle Cells, donor2	11358-117H8	236.37	1.45	4.34	0.72	2.17	2.89
Skeletal Muscle Cells, donor3	11430-118G8	205.67	0.00	7.52	1.67	3.34	0.84
Skeletal Muscle Cells, donor4	11451-119A2	315.13	0.31	8.48	2.67	1.89	1.26
Skeletal Muscle Cells, donor5	11455-119A6	294.32	0.59	7.43	1.64	1.19	0.45
Skeletal Muscle Cells, donor6	11459-119B1	325.20	0.46	7.08	1.39	1.54	0.77
Skeletal Muscle Satellite Cells, donor1	11240-116D7	576.98	0.76	6.68	0.63	1.39	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	322.19	0.57	4.28	1.71	0.86	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	313.60	0.50	7.54	1.29	0.99	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	685.05	0.17	10.36	0.08	0.59	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	202.65	0.00	4.34	0.00	2.17	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	216.03	0.41	5.50	2.06	1.24	0.41
Skin - palm, donor1	10286-104F7	61.78	0.00	0.00	2.69	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	162.32	0.00	3.89	1.01	1.59	1.44
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	182.39	0.82	9.81	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	194.61	0.00	4.93	1.30	1.04	1.30
Small Airway Epithelial Cells, donor1	11256-116F5	293.86	0.56	6.67	0.42	1.39	0.56
Small Airway Epithelial Cells, donor2	11334-117F2	139.67	0.14	2.81	0.84	0.70	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	151.82	0.00	8.25	0.85	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	103.88	0.07	1.20	0.45	0.60	0.52
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	511.94	0.93	5.86	1.54	4.32	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	149.41	0.00	8.00	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	235.13	0.00	1.76	0.00	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	112.04	0.22	5.30	0.00	0.66	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	203.19	0.39	7.88	0.00	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	275.81	0.00	6.18	0.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	676.51	4.00	4.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	254.31	0.13	4.52	0.27	0.27	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	335.14	0.44	7.09	1.77	0.66	1.33
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	173.23	0.51	5.63	0.77	1.41	0.64
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	281.31	0.33	4.88	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	265.20	0.00	6.50	0.00	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	179.38	0.14	2.56	0.28	0.28	0.43
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	68.00	0.00	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	217.37	0.30	0.61	0.00	0.30	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	310.15	0.00	6.31	0.25	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	0.00	6.12	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	161.17	0.48	3.34	1.43	1.43	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	298.63	0.74	4.42	0.29	0.44	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	269.26	1.08	5.38	1.29	1.51	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	263.97	0.21	4.30	1.47	0.94	1.05
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	204.33	0.00	7.12	0.15	0.15	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	91.62	0.00	4.31	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	147.93	0.30	4.18	0.00	2.69	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	86.72	0.00	1.02	0.00	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	691.92	0.16	6.83	0.86	0.71	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	330.61	0.00	6.44	0.50	1.11	1.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	115.60	0.00	4.55	0.68	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	230.66	0.00	6.04	0.00	2.42	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	482.16	0.00	12.98	1.32	0.79	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	295.48	0.27	5.73	0.40	0.27	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	281.62	0.50	5.26	2.38	1.88	1.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	368.32	0.25	2.03	0.76	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	281.04	0.15	7.24	0.15	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	201.04	0.00	3.00	1.50	1.50	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	103.38	0.00	0.00	5.17	1.29	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	298.58	0.00	9.30	0.47	1.40	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	223.16	0.00	4.04	0.50	1.01	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	99.35	0.00	4.70	0.63	1.25	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	79.06	0.00	1.47	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	298.82	0.08	8.25	0.33	0.25	0.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	328.88	0.47	0.93	0.47	0.93	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	245.38	0.29	5.04	0.14	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	239.15	0.25	4.59	1.02	0.51	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	185.59	0.19	3.76	1.13	0.94	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	432.09	0.00	6.01	0.28	1.26	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	485.38	0.25	7.54	0.08	0.08	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	77.62	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	219.71	0.00	3.18	0.49	0.00	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	310.43	0.00	6.19	1.33	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	268.59	0.59	5.85	0.88	0.29	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	249.17	0.39	4.08	0.97	0.97	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	174.54	0.79	2.91	0.53	1.06	1.32
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	426.62	1.12	7.07	2.23	2.23	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	245.07	0.36	3.23	1.08	2.16	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	121.51	0.28	4.26	0.28	0.57	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	285.16	0.79	7.09	0.00	0.39	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	338.26	0.25	3.05	1.02	2.29	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	255.16	0.40	1.60	0.80	1.60	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	291.77	0.00	4.18	1.25	5.02	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	287.39	0.46	2.29	1.83	1.38	0.92
Synoviocyte, donor1	11291-117A4	305.17	0.34	4.04	0.84	0.67	0.34
Synoviocyte, donor2	11368-117I9	309.10	0.34	3.86	1.34	1.17	1.01
Synoviocyte, donor3	11440-118H9	313.67	0.67	3.35	1.12	2.23	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	117.92	0.36	3.93	0.00	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	97.12	0.00	5.95	0.00	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	82.43	0.00	1.62	0.23	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	267.31	0.14	3.87	0.36	0.86	0.36
Tracheal Epithelial Cells, donor2	11369-118A1	189.80	0.00	5.03	0.77	1.16	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	181.53	0.57	4.58	1.15	1.72	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	397.00	0.00	5.54	0.37	0.37	2.95
Urethra, donor2	10319-105A4	125.89	0.00	1.80	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	67.21	0.00	1.33	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	84.12	0.00	0.00	0.40	0.80	0.40
Urothelial Cells, donor3	11681-122H7	65.09	0.00	0.92	0.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	381.82	0.00	3.12	0.00	0.45	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	636.19	1.78	8.90	0.00	1.78	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	587.57	0.00	4.29	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	326.52	0.68	4.79	0.68	1.37	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	573.67	0.34	2.41	0.34	0.69	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	581.61	0.00	3.49	0.00	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	537.28	0.00	6.25	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	569.03	0.92	6.42	0.00	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	323.17	0.91	1.83	1.83	2.74	1.83
Wilms' tumor cell line:G-401	10809-111A8	400.43	0.62	9.75	0.62	1.23	1.36
Wilms' tumor cell line:HFWT	10597-108E3	168.97	0.00	6.16	0.88	0.88	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	330.43	0.28	2.23	0.56	0.00	0.56
achilles tendon, donor2	10292-104G4	140.52	0.00	6.20	2.07	0.00	2.07
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	456.37	0.25	11.22	0.25	1.27	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	836.76	0.23	16.95	0.46	0.70	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	718.78	0.00	6.53	0.47	0.71	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	496.88	0.27	22.59	1.09	0.54	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	416.00	0.56	16.87	0.84	1.41	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	690.27	0.42	11.42	0.63	2.33	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	816.91	0.82	9.26	1.63	1.91	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1211.76	1.76	14.10	1.76	3.97	3.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	1067.86	2.45	19.60	6.13	4.08	3.68
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	825.13	1.55	11.26	3.49	1.55	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	602.23	1.29	14.17	1.84	1.84	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	881.52	0.00	11.70	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	665.54	0.93	26.72	2.32	1.63	0.93
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	866.28	1.04	16.31	1.04	1.04	2.07
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	624.23	0.29	12.27	2.34	2.05	2.05
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	264.91	0.00	2.32	0.00	1.86	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	323.66	0.00	5.76	0.82	1.65	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	42.67	0.00	0.61	0.00	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	592.70	0.00	8.96	1.28	0.85	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	568.68	0.00	8.80	0.91	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	631.85	0.24	7.70	0.72	1.68	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	350.81	0.45	10.25	0.67	0.67	1.11
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	259.50	0.00	6.34	0.33	0.67	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	150.51	0.00	3.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	449.36	0.00	18.83	1.13	2.26	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	349.78	0.00	6.11	0.87	0.44	0.87
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	123.71	0.00	11.25	0.00	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	308.98	0.24	3.06	0.47	0.94	0.47
adipose tissue, adult, pool1	10010-101C1	370.27	0.16	2.48	0.78	1.71	1.86
adipose, donor1	10184-103D4	1948.05	3.52	9.97	9.38	9.38	22.28
adipose, donor2	10185-103D5	471.62	2.03	2.43	2.43	0.41	8.92
adipose, donor3	10186-103D6	444.92	1.36	10.07	3.27	1.36	7.62
adipose, donor4	10187-103D7	514.85	0.00	9.53	2.60	1.73	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	217.95	0.16	3.63	0.32	0.79	0.16
adrenal gland, adult, pool1	10081-102A9	130.96	0.00	3.64	0.00	3.64	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	462.52	0.13	3.34	0.27	0.67	0.80
alveolar cell carcinoma cell line:SW 1573	10708-109H6	306.92	0.71	2.14	1.07	1.79	1.07
amniotic membrane cells, donor1	12235-129G3	162.76	0.23	1.62	0.23	0.93	0.00
amniotic membrane cells, donor2	12236-129G4	315.45	0.68	4.73	0.34	0.68	1.69
amniotic membrane cells, donor3	12237-129G5	280.46	0.29	2.06	0.59	0.59	0.88
amygdala - adult, donor10196	10167-103B5	150.60	1.19	4.74	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	167.69	0.81	3.04	0.41	1.01	0.61
amygdala, newborn, donor10223	10360-105E9	172.04	0.00	4.84	0.97	0.32	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	1011.64	0.64	6.75	1.15	0.76	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	441.69	0.22	10.81	1.76	0.66	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	599.93	0.67	3.34	0.00	1.67	0.67
aorta, adult, pool1	10052-101G7	264.58	0.39	1.18	0.59	0.59	1.77
appendix, adult	10189-103D9	305.45	0.39	2.72	0.78	0.39	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	760.10	0.34	9.97	1.72	0.34	0.34
artery, adult	10190-103E1	403.53	0.00	1.36	1.36	6.79	5.43
astrocytoma cell line:TM-31	10425-106D2	564.11	0.58	16.80	0.72	1.01	0.14
b cell line:RPMI1788	10427-106D4	608.04	0.15	2.53	0.45	0.30	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	266.35	0.83	9.16	0.83	0.83	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	325.48	0.10	6.75	0.10	0.20	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	258.26	0.17	4.69	0.17	0.17	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	568.19	1.12	2.80	1.68	1.68	3.91
bladder, adult, pool1	10011-101C2	466.72	0.22	2.06	1.20	1.96	1.30
blood, adult, pool1	10053-101G8	292.33	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	72.79	0.00	4.28	0.00	0.00	0.00
bone marrow, adult	10192-103E3	282.75	0.67	4.05	2.02	0.00	0.67
brain, adult, donor1	10084-102B3	162.99	0.00	4.10	1.03	0.00	0.00
brain, adult, pool1	10012-101C3	266.59	0.00	4.34	0.33	0.45	0.89
brain, fetal, pool1	10085-102B4	507.57	0.00	8.01	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	290.72	0.33	4.29	0.66	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	470.71	0.00	7.24	0.37	0.12	0.12
breast, adult, donor1	10080-102A8	159.10	1.26	3.16	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	223.84	0.13	9.02	0.64	0.76	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	319.42	0.00	7.42	1.24	0.93	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	694.80	0.00	7.14	0.23	1.61	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	223.45	0.00	5.81	0.00	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	336.17	0.47	3.29	1.88	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	152.91	0.00	2.73	0.33	0.11	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	523.83	0.00	1.27	1.90	1.27	1.58
carcinosarcoma cell line:JHUCS-1	10642-109A3	756.21	0.80	6.39	2.93	1.86	2.13
caudate nucleus - adult, donor10196	10177-103C6	234.87	0.00	3.45	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	240.62	0.33	2.84	0.84	0.67	0.84
caudate nucleus, adult, donor10258	10379-105H1	385.13	0.76	5.35	0.00	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	294.82	0.37	4.39	0.73	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	466.12	0.00	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	362.97	0.00	4.06	0.64	0.85	0.64
cerebellum, adult, pool1	10083-102B2	292.51	0.69	1.72	0.34	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	503.98	1.66	5.81	0.83	2.49	0.00
cerebral meninges, adult	10188-103D8	152.80	0.50	2.52	0.50	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	125.71	0.00	2.19	1.46	2.19	0.00
cervical cancer cell line:D98-AH2	10552-107I3	483.83	0.00	6.76	0.58	0.58	0.58
cervical cancer cell line:ME-180	10553-107I4	415.62	0.50	7.29	0.17	0.33	0.50
cervix, adult, pool1	10013-101C4	608.31	0.00	3.15	0.94	1.36	1.57
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	193.68	0.28	4.74	0.28	0.98	0.28
chondrosarcoma cell line:SW 1353	10700-109G7	97.97	0.00	0.00	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	652.70	0.75	7.58	0.50	0.99	1.62
choriocarcinoma cell line:SCH	10785-110H2	535.48	0.12	7.76	0.74	1.23	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	405.57	0.00	3.56	0.71	1.42	0.95
chorionic membrane cells, donor1	12238-129G6	172.95	0.00	1.42	1.42	0.57	0.57
chorionic membrane cells, donor2	12239-129G7	222.73	0.40	6.46	0.40	0.80	1.49
chorionic membrane cells, donor3	12240-129G8	297.82	0.00	4.40	0.00	3.30	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	487.73	3.03	7.07	3.03	1.01	3.03
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	492.73	0.19	9.99	1.73	1.54	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	293.34	0.00	9.08	0.42	1.48	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	275.03	0.00	2.57	0.51	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	274.53	0.00	3.63	0.48	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	303.58	0.20	2.65	0.00	0.00	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	361.59	0.00	6.18	0.88	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	456.88	0.00	16.68	0.00	0.78	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	543.11	2.74	9.60	5.49	2.51	1.60
clear cell carcinoma cell line:TEN	10636-108I6	296.18	0.35	2.26	0.69	0.52	0.69
colon carcinoma cell line:CACO-2	10513-107D9	411.48	0.18	13.18	0.18	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	973.01	0.38	3.42	0.38	0.00	0.38
colon, adult, donor1	10082-102B1	249.91	0.00	2.38	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	338.53	0.12	2.47	0.47	1.53	1.53
colon, fetal, donor1	10070-101I7	226.18	0.00	3.09	0.62	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	137.51	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	1602.35	0.00	0.00	0.00	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	376.49	0.00	8.92	0.42	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	414.46	0.15	15.70	0.60	1.21	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	459.56	0.14	12.83	0.85	0.42	0.71
corpus callosum, adult, pool1	10042-101F6	301.06	0.00	6.08	0.00	0.11	0.22
cruciate ligament, donor2	10295-104G7	170.20	0.00	2.43	0.81	0.00	0.81
diaphragm, fetal, donor1	10069-101I6	211.88	0.00	2.41	0.80	0.80	0.80
diencephalon, adult	10193-103E4	187.19	0.00	4.80	0.24	1.44	0.96
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	870.46	2.76	10.79	5.28	3.90	2.07
ductal cell carcinoma cell line:KLM-1	10438-106E6	283.88	0.00	9.74	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	268.16	0.48	0.48	0.72	0.24	0.24
ductus deferens, adult	10196-103E7	239.20	0.50	2.99	0.00	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	400.38	2.88	1.44	4.32	1.44	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	521.58	3.68	8.83	1.47	7.36	1.47
dura mater, adult, donor1	10041-101F5	401.37	0.25	3.47	0.50	0.25	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	540.30	0.00	13.77	1.11	2.66	2.44
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	687.81	0.14	17.63	0.86	1.15	1.72
embryonic pancreas cell line:1B2C6	10604-108F1	170.80	0.00	1.23	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	281.82	0.30	1.51	0.91	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	199.14	0.00	2.78	0.31	1.23	0.62
embryonic pancreas cell line:2C6	10603-108E9	190.45	0.00	3.94	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	228.27	0.00	6.70	0.34	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	528.12	0.72	4.53	0.18	0.91	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	400.42	1.93	9.33	2.25	2.09	1.61
epidermoid carcinoma cell line:A431	10426-106D3	209.09	0.00	2.89	0.11	0.33	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	223.27	0.11	7.04	0.00	0.22	0.33
epididymis, adult	10197-103E8	265.41	0.21	2.93	0.84	1.26	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	117.09	0.00	1.06	0.18	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	260.72	0.00	5.90	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	302.46	0.39	5.77	1.31	1.31	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	313.86	0.30	3.44	1.08	0.59	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	268.53	0.34	4.37	1.12	0.78	0.78
esophagus, adult, pool1	10015-101C6	396.57	0.00	2.55	0.42	2.55	2.23
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	859.49	0.00	5.39	0.75	0.63	1.50
eye - muscle inferior rectus, donor1	10272-104E2	77.27	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	90.48	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	38.69	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	95.16	0.00	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	161.77	0.00	4.37	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	421.52	0.76	3.56	1.78	1.02	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	413.91	0.51	10.77	1.03	1.03	1.41
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	207.27	0.00	5.46	0.71	0.47	0.47
frontal lobe, adult, pool1	10040-101F4	289.07	0.00	8.26	0.00	0.47	0.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	158.23	0.30	6.91	0.30	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	281.81	0.00	4.30	0.27	0.09	0.46
gall bladder, adult	10198-103E9	190.01	0.24	2.17	0.72	0.97	1.21
gamma delta positive T cells, donor1	11937-126A2	601.28	0.54	5.91	1.61	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	492.26	0.37	4.48	0.37	1.12	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	253.04	0.42	6.13	2.53	2.53	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	314.30	0.19	4.45	0.58	1.93	0.39
gastric cancer cell line:AZ521	10549-107H9	643.52	0.16	12.30	0.33	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	551.88	0.00	0.00	0.92	1.83	3.66
gastrointestinal carcinoma cell line:ECC12	10615-108G3	419.22	0.23	7.31	1.83	1.83	0.69
giant cell carcinoma cell line:LU65	10487-107B1	472.62	0.00	8.95	0.80	0.80	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	393.43	0.14	2.52	0.28	0.00	0.42
glassy cell carcinoma cell line:HOKUG	10688-109F4	151.15	0.50	2.24	0.50	0.50	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	87.93	0.00	2.11	0.00	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	79.77	0.00	1.69	0.00	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	401.98	0.11	5.52	0.33	0.55	0.44
glioma cell line:GI-1	10413-106B8	451.32	0.00	4.69	0.00	0.88	0.88
globus pallidus - adult, donor10196	10175-103C4	119.54	0.00	1.46	0.00	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	200.89	0.00	2.44	0.73	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	187.58	0.00	1.37	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	159.34	0.53	8.53	1.60	1.60	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	115.02	0.00	4.89	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	1114.69	0.00	10.93	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	1097.58	5.23	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	105.92	0.00	0.64	0.00	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	553.69	0.92	7.35	0.46	0.92	1.38
hIPS +CCl2, biol_rep2	14384-156C1	591.70	0.46	11.89	0.91	2.29	0.91
hIPS +CCl2, biol_rep3	14385-156C2	536.53	0.00	12.24	0.64	0.64	0.64
hIPS, biol_rep1	14380-156B6	365.07	0.00	11.50	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	421.12	0.00	8.92	0.69	4.12	0.69
hIPS, biol_rep3	14382-156B8	265.94	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	382.17	0.57	7.76	0.86	1.44	0.00
heart - mitral valve, adult	10205-103F7	171.61	0.30	3.89	0.90	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	251.02	0.00	3.14	0.00	0.52	0.26
heart - tricuspid valve, adult	10207-103F9	87.43	0.00	2.50	0.83	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	196.30	0.61	4.29	0.82	0.82	0.82
heart, adult, diseased, donor1	10051-101G6	210.79	0.00	5.54	1.70	0.43	0.00
heart, adult, pool1	10016-101C7	126.49	0.00	1.15	0.46	0.23	0.23
heart, fetal, pool1	10046-101G1	602.83	0.00	5.85	0.10	0.62	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	152.41	0.31	2.47	0.31	0.93	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	244.97	0.00	1.19	1.19	1.19	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	269.17	0.11	10.94	0.88	0.99	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	299.19	0.12	11.89	1.58	1.09	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	310.94	0.40	13.14	0.91	0.91	0.40
hepatoma cell line:Li-7	10484-107A7	181.95	0.00	6.01	0.33	0.56	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	415.17	0.30	7.74	0.40	0.30	0.40
hippocampus - adult, donor10196	10169-103B7	169.39	0.00	7.57	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	156.95	0.00	3.06	0.61	1.22	0.20
hippocampus, adult, donor10258	10374-105G5	207.15	0.50	4.98	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	129.01	0.35	1.76	0.35	1.06	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1395.86	3.05	31.74	5.49	9.16	5.49
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	651.90	0.98	12.96	3.53	2.75	2.75
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	764.23	1.78	12.44	2.79	2.79	3.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	975.49	1.69	3.95	5.64	4.51	13.53
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	991.53	7.23	6.97	20.66	27.37	19.88
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	1440.62	3.42	7.97	9.87	7.21	15.94
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	705.65	2.92	9.63	4.67	6.42	13.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	789.11	2.15	8.19	6.25	6.25	18.31
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	646.05	0.83	7.51	2.92	1.25	7.92
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	747.55	1.18	13.50	1.18	3.32	6.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	751.35	1.77	15.75	5.63	2.57	7.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	682.73	1.35	17.51	1.35	3.37	3.37
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	692.91	1.25	11.27	3.60	2.19	3.91
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	846.50	4.91	16.70	9.83	10.81	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1381.57	2.62	27.06	4.36	16.58	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	1041.04	2.10	5.73	4.77	7.45	18.33
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	853.39	2.18	6.54	3.49	2.62	16.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	1075.49	4.00	7.50	7.50	5.00	10.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	854.92	3.96	6.59	6.41	7.35	17.90
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	964.91	3.64	8.64	7.73	7.73	16.37
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	779.96	2.51	4.39	4.07	3.45	7.52
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	623.65	1.96	11.92	3.27	3.59	9.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	598.62	2.61	14.81	3.77	2.61	7.55
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	502.49	2.99	10.76	2.99	1.20	5.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	665.08	0.92	13.86	4.99	3.88	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	610.79	0.29	12.27	2.57	2.57	1.71
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	946.87	1.63	18.78	4.08	4.08	4.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	811.55	3.17	9.15	5.28	7.39	10.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	706.96	6.02	3.80	4.43	3.48	11.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	772.29	3.93	6.66	4.24	4.54	13.01
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	609.69	3.10	12.93	1.55	3.10	8.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	668.82	3.32	6.64	5.31	5.31	7.97
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	612.60	1.28	8.98	3.08	1.80	5.64
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	587.99	4.60	10.48	5.62	4.86	6.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	668.63	3.79	14.39	8.33	3.03	4.54
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	531.31	1.34	10.08	4.03	2.69	7.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	681.53	1.21	11.35	2.90	3.38	2.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	822.69	2.23	16.49	4.90	3.57	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	667.32	2.93	8.29	3.41	3.41	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	961.78	1.22	6.42	5.50	3.67	11.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	6421.90	16.27	39.04	45.55	68.32	113.86
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	1413.12	2.98	11.58	5.30	7.28	20.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	875.68	7.66	13.14	2.74	6.57	14.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	784.20	2.53	10.86	4.34	3.62	8.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	753.74	2.85	14.23	4.63	4.63	13.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	741.09	3.58	11.93	0.00	4.77	11.93
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	848.44	1.63	16.79	2.44	3.39	10.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	504.58	1.08	10.78	1.62	1.62	6.20
immature langerhans cells, donor1	11904-125F5	455.48	0.24	6.54	1.45	1.70	0.48
immature langerhans cells, donor2	11905-125F6	298.63	0.00	1.58	0.00	0.79	1.58
insula, adult, pool1	10039-101F3	299.99	0.09	8.42	0.28	0.28	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	278.33	0.00	5.85	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	289.07	0.00	4.71	0.60	1.30	0.50
kidney, fetal, pool1	10045-101F9	505.62	0.00	5.80	0.28	0.42	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	152.53	0.00	5.68	0.00	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	194.92	0.41	1.94	0.41	0.97	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	205.15	0.00	1.28	0.18	0.00	0.18
left atrium, adult, donor1	10079-102A7	190.70	1.63	1.09	0.54	0.54	0.54
left ventricle, adult, donor1	10078-102A6	170.91	1.01	2.02	1.01	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	361.17	0.00	5.47	0.55	1.09	1.09
leiomyoma cell line:10964C	10569-108B2	263.69	0.72	4.67	3.23	2.87	0.36
leiomyoma cell line:15242A	10570-108B3	166.85	1.09	7.07	1.09	0.00	0.00
leiomyoma cell line:15425	10571-108B4	243.30	0.97	6.56	3.40	1.46	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	279.37	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	127.56	0.00	0.00	1.05	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	236.82	0.00	8.15	0.00	0.35	0.12
liposarcoma cell line:KMLS-1	10782-110G8	263.37	0.00	4.37	0.31	0.31	0.00
liposarcoma cell line:SW 872	10726-110A6	187.63	0.24	4.14	0.37	0.73	0.24
liver, adult, pool1	10018-101C9	361.23	0.16	6.16	0.81	1.13	0.97
liver, fetal, pool1	10086-102B5	130.76	0.00	1.88	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	124.97	0.15	2.19	0.15	0.29	0.00
locus coeruleus, adult, donor10252	10165-103B3	148.56	0.37	4.06	0.37	0.74	0.37
locus coeruleus, adult, donor10258	10375-105G6	178.03	0.56	3.95	1.97	0.85	0.85
locus coeruleus, newborn, donor10223	10362-105F2	262.47	0.00	11.78	0.84	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	207.04	0.00	2.21	0.14	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	249.57	0.00	2.07	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	228.44	0.13	5.54	0.53	0.53	0.66
lung, adult, pool1	10019-101D1	296.74	0.24	1.77	0.24	1.65	1.89
lung, fetal, donor1	10068-101I5	562.54	0.29	5.99	0.86	1.14	1.71
lung, right lower lobe, adult, donor1	10075-102A3	191.99	0.92	2.75	0.46	0.92	0.46
lymph node, adult, donor1	10077-102A5	320.47	0.47	1.42	1.42	1.89	0.95
lymphangiectasia cell line:DS-1	10727-110A7	476.71	0.22	4.16	2.19	0.88	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	567.64	1.21	14.64	1.51	1.06	1.66
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	374.63	0.00	28.88	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	127.87	0.00	1.78	0.44	0.89	0.00
mature adipocyte, donor2	12232-129F9	174.53	0.00	1.66	0.21	0.83	0.21
mature adipocyte, donor3	12233-129G1	201.50	0.00	1.19	0.47	1.19	0.71
mature adipocyte, donor4	12234-129G2	320.07	0.26	2.63	0.26	0.26	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	260.42	0.00	4.77	0.00	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	203.05	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	173.06	0.18	3.13	0.37	0.37	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	168.06	0.00	5.08	0.32	0.64	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	392.37	0.00	15.78	1.71	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	265.95	0.68	8.44	2.36	6.24	0.34
medial temporal gyrus, adult, donor10252	10156-103A3	157.90	0.21	3.82	0.21	0.42	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	140.62	0.00	7.71	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	459.32	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	176.24	0.00	7.54	0.36	0.72	0.36
medulla oblongata - adult, donor10196	10174-103C3	153.16	1.95	2.60	0.65	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	193.50	0.31	2.94	0.15	0.15	0.77
medulla oblongata, adult, pool1	10038-101F2	234.43	0.08	3.27	0.24	0.24	0.16
medulla oblongata, newborn, donor10223	10361-105F1	175.67	0.35	5.55	0.69	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	1334.67	1.77	12.84	2.44	1.77	3.10
medulloblastoma cell line:ONS-76	10759-110E3	116.53	0.00	3.18	0.12	0.73	0.61
melanoma cell line:COLO 679	10514-107E1	227.98	0.43	6.18	0.29	0.29	0.72
melanoma cell line:G-361	10465-106H6	447.10	0.00	10.86	0.54	1.09	2.44
meningioma cell line:HKBMM	10691-109F7	117.23	0.18	1.81	1.45	1.45	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	639.72	0.00	11.46	4.41	2.64	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	321.18	0.26	12.96	1.56	0.26	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	444.65	0.31	11.51	0.77	0.92	0.77
mesenchymal precursor cell - adipose, donor2	11748-123G2	421.91	0.18	6.00	0.91	0.73	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	350.75	0.00	8.70	1.66	1.66	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	423.39	0.42	4.92	0.70	0.42	0.28
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	383.79	0.77	6.16	0.58	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	167.27	0.00	1.39	1.39	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	360.78	0.34	3.95	1.20	1.03	1.20
mesenchymal precursor cell - cardiac, donor2	11753-123G7	361.03	0.46	4.95	0.58	0.92	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	304.27	0.27	8.22	1.33	0.53	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	290.20	0.54	11.34	1.08	0.68	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	238.57	0.28	4.13	0.14	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	377.77	0.66	3.62	0.66	0.33	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	253.22	0.00	4.57	0.55	0.42	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	235.98	0.35	2.44	0.35	0.00	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	289.71	0.00	3.27	0.20	1.02	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	217.83	0.36	3.95	1.44	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	269.38	0.41	3.83	0.41	0.72	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	130.41	0.46	5.02	0.46	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	322.22	0.42	15.52	0.00	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	280.35	0.15	5.53	1.20	0.75	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	290.69	0.18	4.64	0.26	0.53	0.35
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	382.15	0.74	1.10	1.47	0.74	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	212.33	0.29	3.15	2.58	0.86	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	382.28	2.11	12.63	4.63	2.53	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	311.45	0.46	5.02	0.91	0.46	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	331.24	0.26	6.91	0.51	0.77	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	309.66	0.52	4.19	0.26	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	254.48	0.00	4.93	1.54	1.85	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	319.85	1.18	5.65	1.41	0.47	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	324.24	0.34	4.40	1.69	1.02	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	285.30	0.79	6.68	0.39	1.57	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	224.28	0.93	6.95	1.39	1.39	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	483.04	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	360.52	0.29	6.35	1.44	0.87	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	289.14	0.00	6.02	0.45	0.89	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	295.15	0.72	5.29	1.92	0.48	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	228.06	0.00	3.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	265.17	0.34	1.68	1.01	0.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	260.77	0.00	2.87	0.41	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	283.51	0.43	5.58	1.29	0.43	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	303.52	0.00	8.20	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	351.22	0.00	5.16	0.00	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	317.32	0.97	4.55	1.62	0.65	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	328.83	0.00	1.45	1.45	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	324.11	2.13	3.73	4.26	1.07	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	291.94	1.64	3.27	0.82	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	266.27	1.17	6.61	2.33	1.17	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	337.90	6.30	4.20	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	309.96	0.99	2.98	0.99	3.97	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	290.80	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	279.29	0.00	4.74	1.19	2.37	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	314.36	1.22	3.66	2.44	1.22	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	297.58	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	319.22	0.63	3.17	2.53	2.53	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	316.62	0.00	2.41	0.00	0.34	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	367.51	0.00	0.00	0.00	2.15	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	415.15	0.00	0.00	3.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	423.60	0.00	6.89	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	389.54	0.81	5.30	0.81	2.44	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	445.68	0.00	3.18	0.79	1.59	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	410.90	1.77	4.13	1.77	1.18	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	422.36	1.87	2.81	2.49	0.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	499.92	1.34	4.01	1.34	2.67	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	419.85	0.00	2.37	1.18	1.18	8.28
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	382.63	7.70	0.00	2.57	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	389.63	0.00	2.07	0.00	1.38	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	392.38	0.99	7.92	0.00	0.99	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	305.05	1.12	6.73	0.00	1.12	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	384.82	1.27	3.18	1.91	0.64	1.91
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	260.33	0.81	3.63	0.81	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	309.64	0.00	6.54	2.18	6.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	272.42	0.00	1.27	3.80	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	234.26	0.61	6.07	0.61	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	244.02	0.00	0.00	4.52	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	202.63	1.65	4.12	4.12	1.65	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	322.84	0.40	4.56	0.79	0.60	1.19
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	301.78	1.30	2.27	0.97	0.65	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	298.46	3.06	0.00	2.04	1.02	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	93.62	0.00	1.55	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	149.07	0.00	1.42	0.00	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	237.70	0.00	6.49	0.46	0.23	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	136.76	0.00	12.82	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	193.79	0.00	5.24	0.41	0.31	0.21
mesothelioma cell line:Mero-25	10850-111F4	239.44	0.23	7.49	0.91	0.45	0.68
mesothelioma cell line:Mero-41	10851-111F5	231.52	0.24	4.40	0.24	1.22	0.49
mesothelioma cell line:Mero-48a	10852-111F6	165.19	0.22	3.99	0.44	0.22	0.44
mesothelioma cell line:Mero-82	10853-111F7	238.10	0.53	9.20	1.58	1.31	0.26
mesothelioma cell line:Mero-83	10854-111F8	174.14	0.17	4.77	0.34	0.68	0.34
mesothelioma cell line:Mero-84	10855-111F9	167.84	0.25	5.31	0.25	1.01	0.00
mesothelioma cell line:Mero-95	10856-111G1	147.00	0.41	3.73	0.21	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	239.36	0.33	6.46	0.17	0.17	0.66
mesothelioma cell line:NCI-H226	10846-111E9	211.94	0.18	5.79	0.18	1.09	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	217.12	0.00	5.64	0.68	0.51	0.17
mesothelioma cell line:NCI-H28	10845-111E8	401.80	0.51	6.11	1.53	2.29	1.02
mesothelioma cell line:No36	10857-111G2	240.41	0.00	3.91	0.33	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	138.19	0.00	2.44	0.54	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	259.86	0.00	4.41	0.58	1.15	0.38
migratory langerhans cells, donor2	11902-125F3	175.48	0.00	3.30	0.12	0.61	0.49
migratory langerhans cells, donor3	11903-125F4	427.88	0.00	4.31	0.54	1.08	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	108.39	0.65	2.61	1.31	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	132.25	0.00	5.93	1.48	1.27	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	190.74	0.23	4.15	0.46	1.15	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	383.82	0.19	6.85	0.57	0.57	0.95
myelodysplastic syndrome cell line:SKM-1	10772-110F7	1026.15	0.74	9.42	1.85	1.29	0.74
myeloma cell line:PCM6	10474-106I6	456.02	0.00	7.12	0.40	0.79	0.79
myxofibrosarcoma cell line:MFH-ino	10600-108E6	107.04	0.00	4.06	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	216.93	0.00	2.35	0.59	0.98	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	233.55	0.00	3.68	0.11	0.67	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	279.82	0.44	5.15	0.29	0.51	0.07
nasal epithelial cells, donor2	12227-129F4	324.57	0.55	5.52	0.55	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	1240.72	0.23	12.88	0.69	1.61	0.69
neuroblastoma cell line:NB-1	10539-107G8	469.58	0.19	14.03	0.19	0.56	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	509.09	0.42	8.65	1.05	1.27	1.27
neuroblastoma cell line:NH-12	10555-107I6	1668.77	0.37	11.55	1.68	2.24	1.49
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	612.52	0.00	4.03	3.08	3.08	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	677.08	0.79	4.59	3.33	3.17	2.38
neuroectodermal tumor cell line:TASK1	10774-110F9	1005.09	1.41	11.67	3.42	2.21	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	175.47	0.00	3.81	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	132.28	0.00	3.73	0.53	0.27	0.27
neutrophil PMN, donor1	12133-128D9	44.62	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	292.17	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	322.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	1351.95	0.34	17.93	1.35	1.01	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	207.33	0.00	8.81	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	302.01	0.96	3.21	0.00	1.60	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	202.85	1.05	5.52	2.89	0.79	1.05
nucleus accumbens, adult, pool1	10037-101F1	317.68	0.00	9.00	0.19	0.28	0.28
occipital cortex - adult, donor10196	10172-103C1	154.53	0.00	4.12	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	154.85	0.27	2.68	0.54	1.34	0.27
occipital cortex, newborn, donor10223	10355-105E4	233.29	0.00	5.82	0.73	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	134.35	0.00	2.62	0.26	1.57	0.00
occipital lobe, fetal, donor1	10073-102A1	496.47	0.86	5.58	2.57	1.72	1.72
occipital pole, adult, pool1	10036-101E9	230.61	0.00	5.20	0.08	0.16	0.32
olfactory region, adult	10195-103E6	185.32	0.00	4.59	0.76	0.76	0.96
optic nerve, donor1	10277-104E7	110.06	0.00	2.00	4.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	244.90	0.00	3.65	0.11	0.23	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	411.75	0.00	5.08	0.00	0.55	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	272.95	0.85	6.94	2.71	1.19	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	416.18	0.23	6.24	1.04	1.27	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	164.62	0.00	1.47	0.29	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	291.51	0.00	5.61	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	450.84	0.21	5.94	0.21	0.21	1.06
ovary, adult, pool1	10020-101D2	788.61	0.26	3.84	0.52	2.53	2.10
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	239.78	0.18	6.78	0.55	1.10	0.55
pancreas, adult, donor1	10049-101G4	919.94	0.00	5.64	1.88	1.88	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	500.65	0.84	5.87	0.56	1.68	1.68
papillary adenocarcinoma cell line:8505C	10437-106E5	360.30	1.19	3.75	2.04	1.70	0.68
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	326.86	0.33	3.81	0.17	0.17	0.33
paracentral gyrus, adult, pool1	10035-101E8	243.45	0.09	6.13	0.18	0.27	0.18
parietal cortex, adult, donor10258	10373-105G4	244.42	0.00	4.40	0.00	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	140.13	0.00	4.70	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	156.77	0.00	2.28	0.57	0.57	0.57
parietal lobe, adult, pool1	10034-101E7	236.07	0.09	5.29	0.18	0.26	0.18
parietal lobe, fetal, donor1	10072-101I9	686.64	0.00	12.61	3.88	5.82	2.91
parietal lobe, newborn, donor10223	10356-105E5	213.47	0.37	9.35	0.37	0.75	0.00
parotid gland, adult	10199-103F1	614.81	0.00	2.47	0.00	0.62	2.47
penis, adult	10200-103F2	370.07	0.54	2.15	4.30	2.15	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	534.75	0.00	3.16	0.74	0.56	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	167.84	0.29	3.35	0.58	0.15	0.29
pineal gland - adult, donor10196	10179-103C8	67.73	0.00	3.23	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	230.37	0.00	1.78	0.00	1.18	0.59
pineal gland, adult, donor10258	10377-105G8	147.36	0.00	3.14	0.63	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	412.81	0.00	2.02	0.00	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	566.00	0.00	7.82	0.00	1.56	1.04
pituitary gland, adult, donor10258	10378-105G9	474.14	0.00	8.51	0.85	1.70	0.85
placenta, adult, pool1	10021-101D3	337.99	0.11	4.62	0.75	0.97	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	450.91	0.93	5.03	1.32	0.79	0.79
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	239.06	0.16	2.33	0.31	0.16	0.31
pons, adult, pool1	10033-101E6	257.77	0.00	5.16	0.09	0.60	0.09
postcentral gyrus, adult, pool1	10032-101E5	269.20	0.00	6.19	0.44	0.35	0.78
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	1162.20	0.00	5.51	0.00	5.51	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	1067.95	0.00	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	297.15	0.15	3.06	0.44	0.15	0.44
prostate cancer cell line:PC-3	10439-106E7	221.98	0.00	7.62	0.73	0.00	0.18
prostate, adult, pool1	10022-101D4	516.49	0.09	3.54	0.91	1.63	1.18
putamen, adult, donor10196	10176-103C5	303.34	0.24	6.14	1.18	0.94	0.24
putamen, adult, donor10252	10152-102I8	170.58	0.00	1.96	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	333.31	1.09	14.21	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	289.93	0.00	4.83	0.00	1.21	0.48
putamen, newborn, donor10223	10365-105F5	409.32	0.00	16.49	1.50	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	351.74	0.00	5.24	0.87	0.00	0.29
rectum, fetal, donor1	10067-101I4	374.18	1.39	1.39	1.39	2.78	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	310.58	0.21	4.88	0.00	0.85	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	106.45	0.00	0.41	0.41	0.00	0.00
retina, adult, pool1	10030-101E3	365.09	0.20	2.78	0.20	0.80	0.40
retinoblastoma cell line:Y79	10475-106I7	1184.44	0.00	5.46	2.60	2.34	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	274.91	0.25	8.61	0.37	0.74	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	525.00	0.00	10.12	0.56	0.84	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	209.17	0.00	0.76	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	491.72	0.16	5.34	0.65	0.81	1.29
salivary acinar cells, donor2	11772-123I8	745.85	0.55	4.13	1.51	1.65	2.48
salivary acinar cells, donor3	11773-123I9	148.30	0.00	1.32	0.66	0.00	1.32
salivary gland, adult, pool1	10093-102C3	648.02	0.00	8.01	0.00	1.72	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	255.04	0.00	1.85	0.25	0.42	0.67
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	228.99	0.12	2.12	0.12	0.12	0.59
seminal vesicle, adult	10201-103F3	246.55	0.00	1.59	1.06	4.76	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	256.04	0.97	5.83	0.49	1.21	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	297.93	1.51	2.77	0.75	1.76	1.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	256.90	1.00	8.03	3.01	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	562.40	0.27	5.10	1.61	1.07	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	241.95	0.22	5.31	0.22	0.22	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	333.92	0.13	5.42	0.39	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	181.59	0.00	1.42	0.00	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	510.81	0.12	2.64	0.84	1.32	2.52
skeletal muscle, fetal, donor1	10066-101I3	790.95	0.00	3.02	4.02	6.03	5.03
skin, adult, donor1	10074-102A2	427.47	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	447.54	1.89	3.79	7.57	2.52	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	213.79	0.33	6.34	1.00	0.33	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	343.89	0.63	6.30	0.63	1.26	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	692.93	1.16	7.52	2.89	1.16	1.35
small cell lung carcinoma cell line:LK-2	10541-107H1	458.88	0.16	4.29	0.33	0.49	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	889.18	0.48	2.25	1.77	1.13	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	134.02	0.22	9.81	0.22	0.44	0.22
small intestine, adult, pool1	10024-101D6	413.39	0.36	3.94	0.00	2.39	1.79
small intestine, fetal, donor1	10064-101I1	481.32	0.98	4.42	1.72	0.74	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	175.93	0.51	3.08	3.08	0.00	1.54
smooth muscle, adult, pool1	10048-101G3	402.41	0.78	3.10	1.03	1.55	0.78
somatostatinoma cell line:QGP-1	10781-110G7	165.64	0.00	2.68	0.00	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	188.34	0.00	3.44	1.15	0.69	0.23
spinal cord, adult, donor10252	10159-103A6	257.06	0.39	2.76	0.39	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	314.08	2.77	4.15	1.38	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	179.90	0.00	7.32	1.83	1.22	0.61
spinal cord, newborn, donor10223	10359-105E8	327.88	0.00	7.35	0.92	1.38	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	120.68	0.15	2.24	0.30	0.30	0.15
spleen, adult, pool1	10025-101D7	311.79	0.22	3.63	0.33	0.66	1.21
spleen, fetal, pool1	10044-101F8	353.02	0.00	5.96	0.16	0.56	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	308.05	0.00	3.83	0.31	0.21	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	353.93	0.00	5.13	0.00	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	268.38	1.05	10.48	2.80	0.70	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	229.09	0.00	4.30	0.78	0.39	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	300.31	0.11	13.84	0.56	0.45	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	368.11	0.85	8.47	0.85	0.42	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	201.80	0.00	2.96	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	222.14	0.00	2.14	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	425.55	0.57	5.13	6.27	1.71	2.85
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	175.10	0.83	3.74	0.42	1.04	0.21
substantia nigra, adult, donor10258	10371-105G2	214.66	0.00	6.21	1.03	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	166.05	0.00	6.36	0.71	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	335.64	0.46	8.25	0.23	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	230.24	0.25	7.46	0.51	0.34	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	404.57	0.00	12.11	2.85	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	443.49	0.00	9.23	5.71	4.40	2.20
tenocyte, donor1	11763-123H8	328.50	2.09	6.63	2.09	2.44	1.40
tenocyte, donor2	11765-123I1	261.71	1.53	3.82	0.76	0.76	1.53
tenocyte, donor3	11768-123I4	273.55	2.22	4.45	1.11	1.48	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	342.81	0.34	12.75	0.34	2.04	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	458.59	0.15	9.87	1.54	1.70	1.23
teratocarcinoma cell line:PA-1	10807-111A6	494.38	0.00	7.44	0.62	1.08	0.93
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	362.56	0.00	6.09	0.89	0.76	0.89
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	676.55	0.76	5.29	0.38	0.76	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	282.91	0.00	2.40	0.65	0.44	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	375.54	0.98	5.21	1.30	2.61	0.65
testis, adult, pool1	10026-101D8	427.45	0.43	4.83	1.07	2.15	3.44
testis, adult, pool2	10096-102C6	323.43	0.00	5.41	0.90	0.90	0.45
thalamus - adult, donor10196	10168-103B6	142.41	0.00	7.73	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	209.11	0.16	3.59	0.31	0.31	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	201.69	3.08	10.78	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	119.40	0.33	1.98	0.49	0.16	0.16
thalamus, newborn, donor10223	10366-105F6	138.65	0.00	6.33	0.00	1.15	0.58
throat, adult	10209-103G2	357.53	2.00	3.25	3.75	1.50	1.50
throat, fetal, donor1	10061-101H7	359.25	1.52	3.96	2.13	3.05	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	704.70	0.60	11.73	1.79	0.99	0.99
thymus, adult, pool1	10027-101D9	610.01	0.20	6.76	0.70	1.69	1.59
thymus, fetal, pool1	10043-101F7	411.46	0.00	7.69	0.21	0.83	0.52
thyroid carcinoma cell line:KHM-5M	10776-110G2	370.96	0.27	5.19	0.27	0.66	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	486.26	0.42	6.29	1.12	1.26	1.12
thyroid, adult, pool1	10028-101E1	798.67	0.56	8.86	1.21	2.33	1.87
thyroid, fetal, donor1	10060-101H6	216.73	0.00	3.43	1.58	1.05	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	70.83	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	370.50	0.47	2.56	3.72	1.63	1.40
tongue, fetal, donor1	10059-101H5	379.91	0.00	3.94	2.76	1.58	0.00
tonsil, adult, pool1	10047-101G2	493.77	0.10	4.91	0.50	1.00	0.50
trachea, adult, pool1	10029-101E2	329.73	0.00	3.93	0.25	0.49	0.57
trachea, fetal, donor1	10058-101H4	341.99	0.77	3.08	3.08	2.69	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	223.55	0.35	2.48	0.35	0.71	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	313.68	0.00	8.92	0.10	0.20	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	569.71	0.16	4.39	0.94	1.72	0.78
tridermal teratoma cell line:HGRT	10694-109G1	95.13	0.00	1.90	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	342.83	0.25	2.54	0.42	0.68	0.42
umbilical cord, fetal, donor1	10057-101H3	212.82	0.00	4.17	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	601.29	0.00	6.65	0.34	0.68	0.85
uterus, fetal, donor1	10055-101H1	337.36	1.02	4.10	0.00	1.54	0.51
vagina, adult	10204-103F6	256.54	0.00	1.29	0.00	0.65	0.00
vein, adult	10191-103E2	318.06	0.44	4.82	2.85	1.53	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	493.22	0.27	5.87	1.34	0.53	0.00